Discovery and resupply of pharmacologically active plant-derived natural products: A review

Biotechnology Advances

Volumn 33, Issue 8, 2015, Pages 1582-1614

  Atanasov, Atanas G ^a   Waltenberger, Birgit ^b   Pferschy Wenzig, Eva Maria ^c   Linder, Thomas ^d   Wawrosch, Christoph ^a   Uhrin, Pavel ^e   Temml, Veronika ^b   Wang, Limei ^a   Schwaiger, Stefan ^b   Heiss, Elke H ^a   Rollinger, Judith M ^a,b   Schuster, Daniela ^b   Breuss, Johannes M ^e   Bochkov, Valery ^c   Mihovilovic, Marko D ^d   Kopp, Brigitte ^a   Bauer, Rudolf ^c   Dirsch, Verena M ^a   Stuppner, Hermann ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

^c UNIVERSITY OF GRAZ   (Austria)

^d VIENNA UNIVERSITY OF TECHNOLOGY   (Austria)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Computer modeling; Drug discovery; Ethnopharmacology; Medicine; Natural products; Organic synthesis; Pharmacology; Phytochemistry; Plant biotechnology; Plants

Indexed keywords

BIOTECHNOLOGY; COMMERCE; DIAGNOSIS; DRUG PRODUCTS PLANTS; MEDICAL APPLICATIONS; MEDICINE;

COMPUTER MODELING; DRUG DISCOVERY; ETHNOPHARMACOLOGY; NATURAL PRODUCTS; ORGANIC SYNTHESIS; PHARMACOLOGY; PHYTOCHEMISTRY; PLANT BIOTECHNOLOGY; PLANTS;

DRUG PRODUCTS;

BIOTECHNOLOGY; COMPLEXITY; COMPUTER SIMULATION; DRUG DEVELOPMENT; HISTORICAL PERSPECTIVE; INTERDISCIPLINARY APPROACH; LITERATURE REVIEW; MEDICINAL PLANT; PHARMACEUTICAL INDUSTRY; PHYTOCHEMISTRY; PLANT PRODUCT; TRADITIONAL MEDICINE;

BIOLOGICAL PRODUCT;

CHEMISTRY; DRUG DEVELOPMENT; DRUG INDUSTRY; HUMAN; MEDICINAL PLANT;

BIOLOGICAL PRODUCTS; DRUG DISCOVERY; DRUG INDUSTRY; HUMANS; PLANTS, MEDICINAL;

EID: 84940055507     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2015.08.001     Document Type: Review

References (503)

1. Actis-Goretta L., Leveques A., Giuffrida F., Romanov-Michailidis F., Viton F., Barron D., et al. Elucidation of (-)-epicatechin metabolites after ingestion of chocolate by healthy humans. Free Radic. Biol. Med. 2012, 53:787-795.
2. Adams M., Schneider S.V., Kluge M., Kessler M., Hamburger M. Epilepsy in the Renaissance: a survey of remedies from 16th and 17th century German herbals. J. Ethnopharmacol. 2012, 143:1-13.
3. Adekenov S.M., Muchametzhanov M.N., Kagarlitskii A.D., Kuprianov A.N. Arglabin, a new sesquiterpene lactone from Artemisia glabella. Khim Prir Soedin+ 1982, 655-656.
4. Afolayan A.J., Adebola P.O. In vitro propagation: a biotechnological tool capable of solving the problem of medicinal plants decimation in South Africa. Afr. J. Biotechnol. 2004, 3:683-687.
5. Agarwal A., D'Souza P., Johnson T.S., Dethe S.M., Chandrasekaran C. Use of in vitro bioassays for assessing botanicals. Curr. Opin. Biotechnol. 2014, 25:39-44.
6. Ager D.J. Route and process selection. Process Understanding 2011, 17-58. Wiley-VCH, Weinheim. I. Houson (Ed.).
7. Aggarwal B.B., Prasad S., Reuter S., Kannappan R., Yadev V.R., Park B., et al. Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: "reverse pharmacology" and "bedside to bench" approach. Curr. Drug Targets 2011, 12:1595-1653.
8. Ajikumar P.K., Xiao W.H., Tyo K.E., Wang Y., Simeon F., Leonard E., et al. Isoprenoid pathway optimization for Taxol precursor overproduction in Escherichia coli. Science 2010, 330:70-74.
9. Akao T., Yoshino T., Kobashi K., Hattori M. Evaluation of salicin as an antipyretic prodrug that does not cause gastric injury. Planta Med. 2002, 68:714-718.
10. Alali F.Q., El-Elimat T., Li C., Qandil A., Alkofahi A., Tawaha K., et al. New colchicinoids from a native Jordanian meadow saffron, colchicum brachyphyllum: isolation of the first naturally occurring dextrorotatory colchicinoid. J. Nat. Prod. 2005, 68:173-178.
11. Alali F.Q., Gharaibeh A., Ghawanmeh A., Tawaha K., Oberlies N.H. Colchicinoids from Colchicum crocifolium Boiss.: a case study in dereplication strategies for (-)-colchicine and related analogues using LC-MS and LC-PDA techniques. Phytochem. Anal. 2008, 19:385-394.
12. Alkhalfioui F., Magnin T., Wagner R. From purified GPCRs to drug discovery: the promise of protein-based methodologies. Curr. Opin. Pharmacol. 2009, 9:629-635.
13. Alqahtani S., Mohamed L.A., Kaddoumi A. Experimental models for predicting drug absorption and metabolism. Expert Opin. Drug Metab. Toxicol. 2013, 9:1241-1254.
14. Amirkia V., Heinrich M. Alkaloids as drug leads - a predictive structural and biodiversity-based analysis. Phytochem. Lett. 2014, 10:xlviii-liii.
15. Anastas P., Eghbali N. Green chemistry: principles and practice. Chem. Soc. Rev. 2010, 39:301-312.
16. Anastas P., Warner J. Green Chemistry: Theory and Practice 1998, Oxford University Press.
17. Andraos J. Unification of reaction metrics for green chemistry: applications to reaction analysis. Org. Process Res. Dev. 2005, 9:149-163.
18. Andraos J. Global green chemistry metrics analysis algorithm and spreadsheets: evaluation of the material efficiency performances of synthesis plans for oseltamivir phosphate (Tamiflu) as a test case. Org. Process Res. Dev. 2009, 13:161-185.
19. Andraos J., Sayed M. On the use of "Green" metrics in the undergraduate organic chemistry lecture and lab to assess the mass efficiency of organic reactions. J. Chem. Educ. 2007, 84:1004-1010.
20. Anterola A., Shanle E., Perroud P.F., Quatrano R. Production of taxa-4(5),11(12)-diene by transgenic Physcomitrella patens. Transgenic Res. 2009, 18:655-660.
21. Appendino G. Omnia praeclara rara. The quest for ingenol heats up. Angew. Chem. Int. Ed. Engl. 2014, 53:927-929.
22. Appendino G., Tron G.C., Cravotto G., Palmisano G., Jakupovic J. An expeditious procedure for the isolation of ingenol from the seeds of Euphorbia lathyris. J. Nat. Prod. 1999, 62:76-79.
23. Appendino G., Taglialatela-Scafati O., Romano A., Pollastro F., Avonto C., Rubiolo P. Genepolide, a sesterpene gamma-lactone with a novel carbon skeleton from mountain wormwood (Artemisia umbelliformis). J. Nat. Prod. 2009, 72:340-344.
24. Appendino G., Fontana G., Pollastro F. 3.08 - Natural products drug discovery. Comprehensive Natural Products II 2010, 205-236. Elsevier, Oxford. H.-W. Liu, L. Mander (Eds.).
25. Arora R., Mathur A., Mathur A.K. Emerging trends in medicinal plant biotechnology. Medicinal Plant Biotechnology 2010, 1-12.
26. Atanasov A.G., Blunder M., Fakhrudin N., Liu X., Noha S.M., Malainer C., et al. Polyacetylenes from Notopterygium incisum - new selective partial agonists of peroxisome proliferator-activated receptor-gamma. PLoS One 2013, 8:e61755.
27. Atanasov A.G., Wang J.N., Gu S.P., Bu J., Kramer M.P., Baumgartner L., et al. Honokiol: a non-adipogenic PPARgamma agonist from nature. Biochim. Biophys. Acta 2013, 1830:4813-4819.
28. Atkinson C., Berman S., Humbert O., Lampe J.W. In vitro incubation of human feces with daidzein and antibiotics suggests interindividual differences in the bacteria responsible for equol production. J. Nutr. 2004, 134:596-599.
29. Baird L., Swift S., Lleres D., Dinkova-Kostova A.T. Monitoring Keap1-Nrf2 interactions in single live cells. Biotechnol. Adv. 2014, 32:1133-1144.
30. Balunas M.J., Su B., Landini S., Brueggemeier R.W., Kinghorn A.D. Interference by naturally occurring fatty acids in a noncellular enzyme-based aromatase bioassay. J. Nat. Prod. 2006, 69:700-703.
31. Barbosa W.L.R., do Nascimento M.S., do Nascimento Pinto L., Maia F.L.C., Sousa A.J.A., Silva Júnior J.O.C., et al. Selecting Medicinal Plants for Development of Phytomedicine and Use in Primary Health Care, Bioactive Compounds in Phytomedicine 2012, InTech, (Available from: http://www.intechopen.com/books/bioactive-compounds-in-phytomedicine/selecting-medicinal-plants-for-development-of-phytomedicine-and-use-in-primary-health-care). 10.5772/26078. I. Rasooli (Ed.).
32. Barton D.H.R., Kirby G.W. Phenol oxidation and biosynthesis. V. Synthesis of galanthamine. J. Chem. Soc. 1962, 806-817.
33. Bauer R. Chinese drugs as a source of new drug materials in western medicine. Pharm. Unserer Zeit 1994, 23:291-300.
34. Baumgartner R.R., Steinmann D., Heiss E.H., Atanasov A.G., Ganzera M., Stuppner H., et al. Bioactivity-guided isolation of 1,2,3,4,6-Penta-O-galloyl-d-glucopyranose from Paeonia lactiflora roots as a PTP1B inhibitor. J. Nat. Prod. 2010, 73:1578-1581.
35. Baxendale I.R., Deeley J., Griffiths-Jones C.M., Ley S.V., Saaby S., Tranmer G.K. A flow process for the multi-step synthesis of the alkaloid natural product oxomaritidine: a new paradigm for molecular assembly. Chem. Commun. (Camb.) 2006, 2566-2568.
36. Baxendale I.R., Griffiths-Jones C.M., Ley S.V., Tranmer G.K. Preparation of the neolignan natural product grossamide by a continuous-flow process. Synlett 2006, 427-430.
37. Besumbes O., Sauret-Gueto S., Phillips M.A., Imperial S., Rodriguez-Concepcion M., Boronat A. Metabolic engineering of isoprenoid biosynthesis in Arabidopsis for the production of taxadiene, the first committed precursor of Taxol. Biotechnol. Bioeng. 2004, 88:168-175.
38. Beutler J.A. Natural products as a foundation for drug discovery. Curr. Protoc. Pharmacol. 2009, 46. (9 11 1-9 21).
39. Bilyk A., Cooper P.L., Sapers G.M. Varietal differences in distribution of quercetin and kaempferol in onion (Allium cepa L.) tissue. J. Agric. Food Chem. 1984, 32:274-276.
40. Blazevic T., Schaible A.M., Weinhaupl K., Schachner D., Nikels F., Weinigel C., et al. Indirubin-3'-monoxime exerts a dual mode of inhibition towards leukotriene-mediated vascular smooth muscle cell migration. Cardiovasc. Res. 2014, 101:522-532.
41. Bohlin L., Goransson U., Alsmark C., Weden C., Backlund A. Natural products in modern life science. Phytochem. Rev. 2010, 9:279-301.
42. Bohlmann J., Keeling C.I. Terpenoid biomaterials. Plant J. 2008, 54:656-669.
43. Bohr C. Inkulturnahme von bisher aus Wildsammlungen stammenden Wirkstoffpflanzen. Drogenreport 1997, 10:37-39.
44. Bonfill M., Malik S., Mirjalili M.H., Goleniowski M., Cusido R., Palazón J. Production and genetic engineering of terpenoids production in plant cell and organ cultures. Natural Products 2013, 2761-2796. Springer, Berlin. K.G. Ramawat, MJM (Eds.).
45. Bonjoch J., Sole D. Synthesis of strychnine. Chem. Rev. 2000, 100:3455-3482.
46. Booker-Milburn K. Flow chemistry: a light touch to a deadly problem. Nat. Chem. 2012, 4:433-435.
47. Borchardt J.K. The beginnings of drug therapy: ancient Mesopotamian medicine. Drug News Perspect. 2002, 15:187-192.
48. Bowey E., Adlercreutz H., Rowland I. Metabolism of isoflavones and lignans by the gut microflora: a study in germ-free and human flora associated rats. Food Chem. Toxicol. 2003, 41:631-636.
49. Brantner A.H., Asres K., Chakraborty A., Tokuda H., Mou X.Y., Mukainaka T., et al. Crown gall - a plant tumour with biological activities. Phytother. Res. 2003, 17:385-390.
50. Breslow R. Centenary Lecture. Biomimetic chemistry. Chem. Soc. Rev. 1972, 1:553-580.
51. Brusotti G., Cesari I., Dentamaro A., Caccialanza G., Massolini G. Isolation and characterization of bioactive compounds from plant resources: the role of analysis in the ethnopharmacological approach. J. Pharm. Biomed. Anal. 2014, 87:218-228.
52. Bucar F., Wube A., Schmid M. Natural product isolation - how to get from biological material to pure compounds. Nat. Prod. Rep. 2013, 30:525-545.
53. Bulger P.G., Bagal S.K., Marquez R. Recent advances in biomimetic natural product synthesis. Nat. Prod. Rep. 2008, 25:254-297.
54. Burton G., Evans-Illidge E.A. Emerging R and D law: the Nagoya Protocol and its implications for researchers. ACS Chem. Biol. 2014, 9:588-591.
55. Butler M.S. The role of natural product chemistry in drug discovery. J. Nat. Prod. 2004, 67:2141-2153.
56. Butler M.S. Natural products to drugs: natural product derived compounds in clinical trials. Nat. Prod. Rep. 2005, 22:162-195.
57. Butler M.S. Natural products to drugs: natural product-derived compounds in clinical trials. Nat. Prod. Rep. 2008, 25:475-516.
58. Butler M.S., Robertson A.A., Cooper M.A. Natural product and natural product derived drugs in clinical trials. Nat. Prod. Rep. 2014, 31:1612-1661.
59. Butterweck V., Nahrstedt A. What is the best strategy for preclinical testing of botanicals? A critical perspective. Planta Med. 2012, 78:747-754.
60. Camp D., Davis R.A., Campitelli M., Ebdon J., Quinn R.J. Drug-like properties: guiding principles for the design of natural product libraries. J. Nat. Prod. 2012, 75:72-81.
61. Cannon J.S., Overman L.E. Is there no end to the total syntheses of strychnine? Lessons learned in strategy and tactics in total synthesis. Angew. Chem. Int. Ed. Engl. 2012, 51:4288-4311.
62. Canter P.H., Thomas H., Ernst E. Bringing medicinal plants into cultivation: opportunities and challenges for biotechnology. Trends Biotechnol. 2005, 23:180-185.
63. Caporale L.H. Chemical ecology: a view from the pharmaceutical industry. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:75-82.
64. Cardellina J.H., Munro M.H., Fuller R.W., Manfredi K.P., McKee T.C., Tischler M., et al. A chemical screening strategy for the dereplication and prioritization of HIV-inhibitory aqueous natural products extracts. J. Nat. Prod. 1993, 56:1123-1129.
65. Cardoso-Taketa A.T., Pereda-Miranda R., Choi Y.H., Verpoorte R., Villarreal M.L. Metabolic profiling of the Mexican anxiolytic and sedative plant Galphimia glauca using nuclear magnetic resonance spectroscopy and multivariate data analysis. Planta Med. 2008, 74:1295-1301.
66. Carr R., Ciccone F., Gabel R., Guinn M., Johnston D., Mastriona J., et al. Streamlined process for the esterification and ketalization of shikimic acid en route to the key precursor for oseltamivir phosphate (Tamiflu). Green Chem. 2008, 10:743-745.
67. Chaturvedi H.C., Jain M., Kidwai N.R. Cloning of medicinal plants through tissue culture - a review. Indian J. Exp. Biol. 2007, 45:937-948.
68. Chemler J.A., Koffas M.A. Metabolic engineering for plant natural product biosynthesis in microbes. Curr. Opin. Biotechnol. 2008, 19:597-605.
69. Chen J., Ma X., Gao K., Wang Y., Zhao H., Wu H., et al. The active ingredients of Jiang-Zhi-Ning: study of the Nelumbo nucifera alkaloids and their main bioactive metabolites. Molecules 2012, 17:9855-9867.
70. Chen X., Zhou L., Tian K., Kumar A., Singh S., Prior B.A., et al. Metabolic engineering of Escherichia coli: a sustainable industrial platform for bio-based chemical production. Biotechnol. Adv. 2013, 31:1200-1223.
71. Cheng J.T. Review: drug therapy in Chinese traditional medicine. J. Clin. Pharmacol. 2000, 40:445-450.
72. Cho K.J., Han S.H., Kim B.Y., Hwang S.G., Park K.K., Yang K.H., et al. Chlorophyllin suppression of lipopolysaccharide-induced nitric oxide production in RAW 264.7 cells. Toxicol. Appl. Pharmacol. 2000, 166:120-127.
73. Choi Y.H., Verpoorte R. Metabolomics: what you see is what you extract. Phytochem. Anal. 2014, 25:289-290.
74. Clardy J., Walsh C. Lessons from natural molecules. Nature 2004, 432:829-837.
75. Coan K.E., Ottl J., Klumpp M. Non-stoichiometric inhibition in biochemical high-throughput screening. Expert Opin. Drug Discovery 2011, 6:405-417.
76. Cohen P., Alessi D.R. Kinase drug discovery - what's next in the field?. ACS Chem. Biol. 2013, 8:96-104.
77. Coley P.D., Heller M.V., Aizprua R., Araúz B., Flores N., Correa M., et al. Using ecological criteria to design plant collection strategies for drug discovery. Front. Ecol. Environ. 2003, 1:421-428.
78. Collins R.A., Ng T.B., Fong W.P., Wan C.C., Yeung H.W. Removal of polyphenolic compounds from aqueous plant extracts using polyamide minicolumns. Biochem. Mol. Biol. Int. 1998, 45:791-796.
79. Conrad J., Dinchev D., Klaiber I., Mika S., Kostova I., Kraus W. A novel furostanol saponin from Tribulus terrestris of Bulgarian origin. Fitoterapia 2004, 75:117-122.
80. Constable D.J.C., Curzons A.D., Cunningham V.L. Metrics to 'green chemistry' - which are the best?. Green Chem. 2002, 4:521-527.
81. Cook D., Lee S.T., Taylor C.M., Bassuner B., Riet-Correa F., Pfister J.A., et al. Detection of toxic monofluoroacetate in Palicourea species. Toxicon 2014, 80:9-16.
82. Cordell G.A. Sustainable medicines and global health care. Planta Med. 2011, 77:1129-1138.
83. Corey E.J., Cheng X.-M. The Logic of Chemical Synthesis 1989, Wiley, New York.
84. Corson T.W., Crews C.M. Molecular understanding and modern application of traditional medicines: triumphs and trials. Cell 2007, 130:769-774.
85. Cos P., Vlietinck A.J., Berghe D.V., Maes L. Anti-infective potential of natural products: how to develop a stronger in vitro 'proof-of-concept'. J. Ethnopharmacol. 2006, 106:290-302.
86. Cragg G.M. Paclitaxel (Taxol): a success story with valuable lessons for natural product drug discovery and development. Med. Res. Rev. 1998, 18:315-331.
87. Cragg G.M., Newman D.J. Natural products: a continuing source of novel drug leads. Biochim. Biophys. Acta 2013, 1830:3670-3695.
88. Cragg G.M., Schepartz S.A., Suffness M., Grever M.R. The taxol supply crisis. New NCI policies for handling the large-scale production of novel natural product anticancer and anti-HIV agents. J. Nat. Prod. 1993, 56:1657-1668.
89. Cragg G.M., Katz F., Newman D.J., Rosenthal J. The impact of the United Nations Convention on Biological Diversity on natural products research. Nat. Prod. Rep. 2012, 29:1407-1423.
90. Creek D.J., Jankevics A., Breitling R., Watson D.G., Barrett M.P., Burgess K.E. Toward global metabolomics analysis with hydrophilic interaction liquid chromatography-mass spectrometry: improved metabolite identification by retention time prediction. Anal. Chem. 2011, 83:8703-8710.
91. Curtis C.G., Bilyard K., Stephenson H. Ex Vivo Metrics, a preclinical tool in new drug development. J. Transl. Med. 2008, 6:5.
92. Curzons A.D., Mortimer D.N., Constable D.J.C., Cunningham V.L. So you think your process is green, how do you know? - Using principles of sustainability to determine what is green - a corporate perspective. Green Chem. 2001, 3:1-6.
93. Czollner L., Frohlich J., Jordis U., Kuenburg B. Preparation of derivatives of 4a,5,9,10,11,12-hexahydro-6H-benzofuro[3a,3,2-ef][2]benzazepine. Application: US: (Sanochemia Pharmazeutika A.-G., Austria) 2000, 28. (Cont -in-part of U S Ser No 487,102, abandoned).
94. David B., Wolfender J.L., Dias D.A. The pharmaceutical industry and natural products: historical status and new trends. Phytochem. Rev. 2015, 14(2):299-315.
95. De Luca V., Salim V., Atsumi S.M., Yu F. Mining the biodiversity of plants: a revolution in the making. Science 2012, 336:1658-1660.
96. Debnath M., Malik C.P., Bisen P.S. Micropropagation: a tool for the production of high quality plant-based medicines. Curr. Pharm. Biotechnol. 2006, 7:33-49.
97. Deng X.H., Fang F.F., Zheng C.J., Wu Y., Qin L.P. Monoterpenoids from the whole herb of Veronicastrum axillare. Pharm. Biol. 2014, 52:661-663.
98. Denis J.N., Greene A.E., Guenard D., Gueritte-Voegelein F., Mangatal L., Potier P. Highly efficient, practical approach to natural taxol. J. Am. Chem. Soc. 1988, 110:5917-5919.
99. Dicks A., Hent A. Green Chemistry Metrics 2015, Springer International Publishing. 1 ed.
100. Doma M., Abhayankar G., Reddy V.D., Kavi Kishor P.B. Carbohydrate and elicitor enhanced withanolide (withaferin A and withanolide A) accumulation in hairy root cultures of Withania somnifera (L.). Indian J. Exp. Biol. 2012, 50:484-490.
101. Dörnenburg H., Knorr D. Strategies for the improvement of secondary metabolite production in plant cell cultures. Enzym. Microb. Technol. 1995, 17:674-684.
102. Drahl C. Chemists find more efficient total synthesis route to Ingenol. Chem. Eng. News 2013, 91:16-16.
103. Dunn W.B., Bailey N.J., Johnson H.E. Measuring the metabolome: current analytical technologies. Analyst 2005, 130:606-625.
104. Duwensee K., Schwaiger S., Tancevski I., Eller K., van Eck M., Markt P., et al. Leoligin, the major lignan from Edelweiss, activates cholesteryl ester transfer protein. Atherosclerosis 2011, 219:109-115.
105. Ebada S.S., Edrada R.A., Lin W., Proksch P. Methods for isolation, purification and structural elucidation of bioactive secondary metabolites from marine invertebrates. Nat. Protoc. 2008, 3:1820-1831.
106. Eckelbarger J.D., Wilmot J.T., Epperson M.T., Thakur C.S., Shum D., Antczak C., et al. Synthesis of antiproliferative Cephalotaxus esters and their evaluation against several human hematopoietic and solid tumor cell lines: uncovering differential susceptibilities to multidrug resistance. Chemistry 2008, 14:4293-4306.
107. Eddershaw P.J., Beresford A.P., Bayliss M.K. ADME/PK as part of a rational approach to drug discovery. Drug Discov. Today 2000, 5:409-414.
108. Egan P.A., van der Kooy F. Coproduction and ecological significance of naphthoquinones in carnivorous sundews (Drosera). Chem. Biodivers. 2012, 9:1033-1044.
109. Eichhorn J., Takada T., Kita Y., Zenk M.H. Biosynthesis of the Amaryllidaceae alkaloid galanthamine. Phytochemistry 1998, 49:1037-1047.
110. Eisenberg D.M., Harris E.S., Littlefield B.A., Cao S., Craycroft J.A., Scholten R., et al. Developing a library of authenticated Traditional Chinese Medicinal (TCM) plants for systematic biological evaluation - rationale, methods and preliminary results from a Sino-American collaboration. Fitoterapia 2011, 82:17-33.
111. Ekuadzi E., Dickson R., Fleischer T., Annan K., Pistorius D., Oberer L., et al. Flavonoid glycosides from the stem bark of Margaritaria discoidea demonstrate antibacterial and free radical scavenging activities. Phytother. Res. 2014, 28:784-787.
112. Eldridge G.R., Vervoort H.C., Lee C.M., Cremin P.A., Williams C.T., Hart S.M., et al. High-throughput method for the production and analysis of large natural product libraries for drug discovery. Anal. Chem. 2002, 74:3963-3971.
113. EMA EMA Committee on Herbal Medicinal Products (HMPC): Guideline on Good Agricultural and Collection Practice for Starting Materials of Herbal Origin 2006.
114. Endoma M.A., Bui V.P., Hansen J., Hudlicky T. Medium-scale preparation of useful metabolites of aromatic compounds via whole-cell fermentation with recombinant organisms. Org. Process Res. Dev. 2002, 6:525-532.
115. Engels B., Dahm P., Jennewein S. Metabolic engineering of taxadiene biosynthesis in yeast as a first step towards Taxol (Paclitaxel) production. Metab. Eng. 2008, 10:201-206.
116. EPA Green Chemistry Program Fact Sheet 2002.
117. Fabricant D.S., Farnsworth N.R. The value of plants used in traditional medicine for drug discovery. Environ. Health Perspect. 2001, 109(Suppl. 1):69-75.
118. Fakhrudin N., Ladurner A., Atanasov A.G., Heiss E.H., Baumgartner L., Markt P., et al. Computer-aided discovery, validation, and mechanistic characterization of novel neolignan activators of peroxisome proliferator-activated receptor gamma. Mol. Pharmacol. 2010, 77:559-566.
119. Fakhrudin N., Waltenberger B., Cabaravdic M., Atanasov A.G., Malainer C., Schachner D., et al. Identification of plumericin as a potent new inhibitor of the NF-kappaB pathway with anti-inflammatory activity in vitro and in vivo. Br. J. Pharmacol. 2014, 171:1676-1686.
120. Fallarero A., Hanski L., Vuorela P. How to translate a bioassay into a screening assay for natural products: general considerations and implementation of antimicrobial screens. Planta Med. 2014, 80:1182-1199.
121. Farhi M., Marhevka E., Ben-Ari J., Algamas-Dimantov A., Liang Z., Zeevi V., et al. Generation of the potent anti-malarial drug artemisinin in tobacco. Nat. Biotechnol. 2011, 29:1072-1074.
122. Farhi M., Kozin M., Duchin S., Vainstein A. Metabolic engineering of plants for artemisinin synthesis. Biotechnol. Genet. Eng. Rev. 2013, 29:135-148.
123. Farnsworth N.R., Akerele O., Bingel A.S., Soejarto D.D., Guo Z. Medicinal plants in therapy. Bull. World Health Organ. 1985, 63:965-981.
124. Feher M., Schmidt J.M. Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry. J. Chem. Inf. Comput. Sci. 2003, 43:218-227.
125. Felter H.W., Lloyd J.U. King's American Dispensatory 1898, Ohio Valley Co, Cincinnatti, (Online source: http://wwwhenriettes-herbcom/eclectic/kings/indexhtml.).
126. Fernandez-Castane A., Feher T., Carbonell P., Pauthenier C., Faulon J.L. Computer-aided design for metabolic engineering. J. Biotechnol. 2014, 192:302-313. (Pt B).
127. Fernando D.R., Marshall A.T., Forster P.I., Hoebee S.E., Siegele R. Multiple metal accumulation within a manganese-specific genus. Am. J. Bot. 2013, 100:690-700.
128. Forbey J.S., Harvey A.L., Huffman M.A., Provenza F.D., Sullivan R., Tasdemir D. Exploitation of secondary metabolites by animals: a response to homeostatic challenges. Integr. Comp. Biol. 2009, 49:314-328.
129. Foster J.R., Lund G., Sapelnikova S., Tyrrell D.L., Kneteman N.M. Chimeric rodents with humanized liver: bridging the preclinical/clinical trial gap in ADME/toxicity studies. Xenobiotica 2014, 44:109-122.
130. Franz C. Kultivierung bedeutender wildwachsender Arznei- und Gewürzpflanzen. Entw ländl raum. 1991, 4:3-7.
131. Frense D. Taxanes: perspectives for biotechnological production. Appl. Microbiol. Biotechnol. 2007, 73:1233-1240.
132. Fürst R., Zündorf I. Plant-derived anti-inflammatory compounds: hopes and disappointments regarding the translation of preclinical knowledge into clinical progress. Mediat. Inflamm. 2014, 2014:2014:146832. 10.1155/2014/.
133. Fürstner A. Metathesis in total synthesis. Chem. Commun. (Camb.) 2011, 47:6505-6511.
134. Gaascht F., Teiten M.H., Cerella C., Dicato M., Bagrel D., Diederich M. Plumbagin modulates leukemia cell redox status. Molecules 2014, 19:10011-10032.
135. Gairola S., Sharma J., Bedi Y.S. A cross-cultural analysis of Jammu, Kashmir and Ladakh (India) medicinal plant use. J. Ethnopharmacol. 2014, 155:925-986.
136. Gao L., Zhang L., Li N., Liu J.Y., Cai P.L., Yang S.L. New triterpenoid saponins from Patrinia scabiosaefolia. Carbohydr. Res. 2011, 346:2881-2885.
137. Gaulton A., Bellis L.J., Bento A.P., Chambers J., Davies M., Hersey A., et al. ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res. 2012, 40:D1100-D1107.
138. Gavernet L., Talevi A., Castro E.A., Bruno-Blanch L.E. A combined virtual screening 2D and 3D QSAR methodology for the selection of new anticonvulsant candidates from a natural product library. QSAR Comb. Sci. 2008, 27:1120-1129.
139. Georgiev M.I., Pavlov A.I., Bley T. Hairy root type plant in vitro systems as sources of bioactive substances. Appl. Microbiol. Biotechnol. 2007, 74:1175-1185.
140. Georgiev M.I., Agostini E., Ludwig-Muller J., Xu J. Genetically transformed roots: from plant disease to biotechnological resource. Trends Biotechnol. 2012, 30:528-537.
141. Gertsch J. Botanical drugs, synergy, and network pharmacology: forth and back to intelligent mixtures. Planta Med. 2011, 77:1086-1098.
142. Gezginci M.H., Timmermann B.N. A short synthetic route to nordihydroguaiaretic acid (NDGA) and its stereoisomer using Ti-induced carbonyl-coupling reaction. Tetrahedron Lett. 2001, 42:6083-6085.
143. Ghavimi B., Magnus P. Total synthesis of 8,14-dihydromorphinandienone alkaloids. Org. Lett. 2014, 16:1708-1711.
144. Gibert Y., Trengove M.C., Ward A.C. Zebrafish as a genetic model in pre-clinical drug testing and screening. Curr. Med. Chem. 2013, 20:2458-2466.
145. Gilbert N. Biodiversity law could stymie research. Nature 2010, 463:598.
146. Gleeson M.P., Hersey A., Montanari D., Overington J. Probing the links between in vitro potency, ADMET and physicochemical parameters. Nat. Rev. Drug Discov. 2011, 10:197-208.
147. Glenn W.S., Runguphan W., O'Connor S.E. Recent progress in the metabolic engineering of alkaloids in plant systems. Curr. Opin. Biotechnol. 2013, 24:354-365.
148. Gosset G. Production of aromatic compounds in bacteria. Curr. Opin. Biotechnol. 2009, 20:651-658.
149. Gras J. Ingenol mebutate: a new option for actinic keratosis treatment. Drugs Today (Barc.) 2013, 49:15-22.
150. Graz B. What is "clinical data"? Why and how can they be collected during field surveys on medicinal plants?. J. Ethnopharmacol. 2013, 150:775-779.
151. Grienke U., Mihaly-Bison J., Schuster D., Afonyushkin T., Binder M., Guan S.H., et al. Pharmacophore-based discovery of FXR-agonists. Part II: identification of bioactive triterpenes from Ganoderma lucidum. Bioorg. Med. Chem. 2011, 19:6779-6791.
152. Grienke U., Braun H., Seidel N., Kirchmair J., Richter M., Krumbholz A., et al. Computer-guided approach to access the anti-influenza activity of licorice constituents. J. Nat. Prod. 2014, 77:563-570.
153. Guasch L., Ojeda M.J., Gonzalez-Abuin N., Sala E., Cereto-Massague A., Mulero M., et al. Identification of novel human dipeptidyl peptidase-IV inhibitors of natural origin (part I): virtual screening and activity assays. PLoS One 2012, 7:e44971.
154. Guenard D., Gueritte-Voegelein F., Potier P. Taxol and taxotere: discovery, chemistry, and structure-activity relationships. Acc. Chem. Res. 1993, 26:160-167.
155. Guerrero L., Margalef M., Pons Z., Quinones M., Arola L., Arola-Arnal A., et al. Serum metabolites of proanthocyanidin-administered rats decrease lipid synthesis in HepG2 cells. J. Nutr. Biochem. 2013, 24:2092-2099.
156. Guillon S., Tremouillaux-Guiller J., Pati P.K., Rideau M., Gantet P. Harnessing the potential of hairy roots: dawn of a new era. Trends Biotechnol. 2006, 24:403-409.
157. Gul S., Gribbon P. Exemplification of the challenges associated with utilising fluorescence intensity based assays in discovery. Expert Opin. Drug Discovery 2010, 5:681-690.
158. Gulcemal D., Masullo M., Napolitano A., Karayildirim T., Bedir E., Alankus-Caliskan O., et al. Oleanane glycosides from Astragalus tauricolus: isolation and structural elucidation based on a preliminary liquid chromatography-electrospray ionization tandem mass spectrometry profiling. Phytochemistry 2013, 86:184-194.
159. Gulcin I. Antioxidant activity of food constituents: an overview. Arch. Toxicol. 2012, 86:345-391.
160. Gunawardana G.P., Premachandran U., Burres N.S., Whittern D.N., Henry R., Spanton S., et al. Isolation of 9-dihydro-13-acetylbaccatin III from Taxus canadensis. J. Nat. Prod. 1992, 55:1686-1689.
161. Guo J., Liu D., Nikolic D., Zhu D., Pezzuto J.M., van Breemen R.B. In vitro metabolism of isoliquiritigenin by human liver microsomes. Drug Metab. Dispos. 2008, 36:461-468.
162. Guo Y., Liu Y.X., Kang L.P., Zhang T., Yu H.S., Zhao Y., et al. Two novel furostanol saponins from the tubers of Ophiopogon japonicus. J. Asian Nat. Prod. Res. 2013, 15:459-465.
163. Guo D.A., Bauer R., Robinson N. The therapeutic value of natural products derived from Chinese medicine - a systems based perspective. Eur. J. Intern. Med. 2014, 6:617-620.
164. Gyllenhaal C., Kadushin M.R., Southavong B., Sydara K., Bouamanivong S., Xaiveu M., et al. Ethnobotanical approach versus random approach in the search for new bioactive compounds: support of a hypothesis. Pharm. Biol. 2012, 50:30-41.
165. Haberlandt G. Culturversuche mit isolierten Pflanzenzellen. Sitzungsber. Akad. Wiss. Wien. Math. Nat. 1902, 111:69-91.
166. Han J.-c., Li F., Li C.-c. Collective synthesis of humulanolides using a metathesis cascade reaction. J. Am. Chem. Soc. 2014, 136:13610-13613.
167. Hanke T., Dehm F., Liening S., Popella S.D., Maczewsky J., Pillong M., et al. Aminothiazole-featured pirinixic acid derivatives as dual 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 inhibitors with improved potency and efficiency in vivo. J. Med. Chem. 2013, 56:9031-9044.
168. Harinantenaina L., Matsunami K., Otsuka H. Chemical and biologically active constituents of Pteris multifida. J. Nat. Med. 2008, 62:452-455.
169. Harrington P.J., Brown J.D., Foderaro T., Hughes R.C. Research and development of a second-generation process for oseltamivir phosphate, prodrug for a neuraminidase inhibitor. Org. Process Res. Dev. 2004, 8:86-91.
170. Harrison C. Patenting natural products just got harder. Nat. Biotechnol. 2014, 32:403-404.
171. Harrison M.M., Jenkins B.V., O'Connor-Giles K.M., Wildonger J. A CRISPR view of development. Genes Dev. 2014, 28:1859-1872.
172. Hartler J., Trötzmüller M., Chitraju C., Spener F., Köfeler H.C., Thallinger G.G. Lipid Data Analyzer: unattended identification and quantitation of lipids in LC-MS data. Bioinformatics 2011, 27:572-577.
173. Hassig C.A., Zeng F.Y., Kung P., Kiankarimi M., Kim S., Diaz P.W., et al. Ultra-high-throughput screening of natural product extracts to identify proapoptotic inhibitors of Bcl-2 family proteins. J. Biomol. Screen. 2014, 19:1201-1211.
174. Hayashi H., Cuddy M., Shu V.C., Yip K.W., Madiraju C., Diaz P., et al. Versatile assays for high throughput screening for activators or inhibitors of intracellular proteases and their cellular regulators. PLoS One 2009, 4:e7655.
175. Hein M., Zilian D., Sotriffer C.A. Docking compared to 3D-pharmacophores: the scoring function challenge. Drug Discov. Today Technol. 2010, 7:e229-e236.
176. Heinrich M. Ethnopharmacology in the 21st century - grand challenges. Front. Pharmacol. 2010, 1:8.
177. Heinrich M. 3.12 - Ethnopharmacology and drug discovery. Comprehensive Natural Products II 2010, 351-381. Elsevier, Oxford. H.-W. Liu, L. Mander (Eds.).
178. Heinrich M., Gibbons S. Ethnopharmacology in drug discovery: an analysis of its role and potential contribution. J. Pharm. Pharmacol. 2001, 53:425-432.
179. Heinstein P., El-Shagi H. Formation of gossypol by Gossypium hirsutum L. cell suspension cultures. J. Nat. Prod. 1981, 44:1-6.
180. Heiss E.H., Tran T.V., Zimmermann K., Schwaiger S., Vouk C., Mayerhofer B., et al. Identification of chromomoric acid C-I as an Nrf2 activator in Chromolaena odorata. J. Nat. Prod. 2014, 77:503-508.
181. Henrich C.J., Beutler J.A. Matching the power of high throughput screening to the chemical diversity of natural products. Nat. Prod. Rep. 2013, 30:1284-1298.
182. Henrich C.J., Bokesch H.R., Dean M., Bates S.E., Robey R.W., Goncharova E.I., et al. A high-throughput cell-based assay for inhibitors of ABCG2 activity. J. Biomol. Screen. 2006, 11:176-183.
183. Hermann J.C., Chen Y., Wartchow C., Menke J., Gao L., Gleason S.K., et al. Metal impurities cause false positives in high-throughput screening campaigns. ACS Med. Chem. Lett. 2013, 4:197-200.
184. Hohmann J., Evanics F., Berta L., Bartok T. Diterpenoids from Euphorbia peplus. Planta Med. 2000, 66:291-294.
185. Holton R.A. Method for preparation of taxol. Application: EP: (Florida State University, USA) 1990, 18.
186. Hong J. Natural product synthesis at the interface of chemistry and biology. Chemistry 2014, 20:10204-10212.
187. Hoon S., St Onge R.P., Giaever G., Nislow C. Yeast chemical genomics and drug discovery: an update. Trends Pharmacol. Sci. 2008, 29:499-504.
188. Horvath I.T., Anastas P.T. Introduction: green chemistry. Chem. Rev. 2007, 107:2167-2168.
189. Hostanska K., Melzer J., Rostock M., Suter A., Saller R. Alteration of anti-inflammatory activity of Harpagophytum procumbens (devil's claw) extract after external metabolic activation with S9 mix. J. Pharm. Pharmacol. 2014, 66:1606-1614.
190. Hosztafi S. The discovery of alkaloids. Pharmazie 1997, 52:546-550.
191. Hou C.C., Chen C.H., Yang N.S., Chen Y.P., Lo C.P., Wang S.Y., et al. Comparative metabolomics approach coupled with cell- and gene-based assays for species classification and anti-inflammatory bioactivity validation of Echinacea plants. J. Nutr. Biochem. 2010, 21:1045-1059.
192. Howat S., Park B., Oh I.S., Jin Y.W., Lee E.K., Loake G.J. Paclitaxel: biosynthesis, production and future prospects. N. Biotechnol. 2014, 31:242-245.
193. Hsu P., Tien H. Studies on the components of Formosan Solanum species. Part I Alkaloids of Solanum incanum, Tai-wan Yao Hsueh Tsa Chih 1974, 26:102338t.
194. Huang W., Zhang J., Wei P., Schrader W.T., Moore D.D. Meclizine is an agonist ligand for mouse constitutive androstane receptor (CAR) and an inverse agonist for human CAR. Mol. Endocrinol. 2004, 18:2402-2408.
195. Huang H.C., Tsai W.J., Liaw C.C., Wu S.H., Wu Y.C., Kuo Y.H. Anti-platelet aggregation triterpene saponins from the galls of Sapindus mukorossi. Chem. Pharm. Bull. (Tokyo) 2007, 55:1412-1415.
196. Huang P., Xiao A., Zhou M., Zhu Z., Lin S., Zhang B. Heritable gene targeting in zebrafish using customized TALENs. Nat. Biotechnol. 2011, 29:699-700.
197. Huang B., Lin H., Yan C., Qiu H., Qiu L., Yu R. Optimal inductive and cultural conditions of Polygonum multiflorum transgenic hairy roots mediated with Agrobacterium rhizogenes R1601 and an analysis of their anthraquinone constituents. Pharmacogn. Mag. 2014, 10:77-82.
198. Hudlicky T. Chemoenzymatic synthesis of complex natural andunnatural products: morphine, pancratistatin, and their analogs. ARKIVOC 2006, 276-291.
199. Hudlický T., Reed J.W. The Way of Synthesis: Evolution of Design and Methods for Natural Products 2007, Wiley-VCH, Weinheim.
200. Hudlicky T., Reed J.W. Celebrating 20 years of SYNLETT - special account on the merits of biocatalysis and the impact of arene cis-dihydrodiols on enantioselective synthesis. Synlett 2009, 685-703.
201. Huffman M.A. Animal self-medication and ethno-medicine: exploration and exploitation of the medicinal properties of plants. Proc. Nutr. Soc. 2003, 62:371-381.
202. Hunter P. Harnessing nature's wisdom. Turning to nature for inspiration and avoiding her follies. EMBO Rep. 2008, 9:838-840.
203. Imming P., Sinning C., Meyer A. Drugs, their targets and the nature and number of drug targets. Nat. Rev. Drug Discov. 2006, 5:821-834.
204. Inui T., Wang Y., Pro S.M., Franzblau S.G., Pauli G.F. Unbiased evaluation of bioactive secondary metabolites in complex matrices. Fitoterapia 2012, 83:1218-1225.
205. IUCN Numbers of threatened species by major groups of organisms (1996-2015) 2015, http://cmsdocs.s3.amazonaws.com/summarystats/2015_2_Summary_Stats_Page_Documents/2015_2_RL_Stats_Table_1.pdf.
206. Jackson D.E., Dewick P.M. Biosynthesis of Podophyllum lignans - II. Interconversions of aryltetralin lignans in Podophyllum hexandrum. Phytochemistry 1984, 23:1037-1042.
207. Janaki N., Bose J. An improved method for the isolation of curcumin from turmeric, Curcuma longa L. J. Indian Chem. Soc. 1967, 44:985-986.
208. Jang S.-H., Yu J.-Y., Lee E.K., Lim M.J., Hong N.J., Oh I.S., et al. In vivo anti-oxidant and anti-inflammatory activities of cambial meristematic cells established from Ginkgo biloba L. J. Med. Plant Res. 2012, 6:3048-3058.
209. Jankevics A., Merlo M.E., de Vries M., Vonk R.J., Takano E., Breitling R. Separating the wheat from the chaff: a prioritisation pipeline for the analysis of metabolomics datasets. Metabolomics 2012, 8:29-36.
210. Jensen M.K., Keasling J.D. Recent applications of synthetic biology tools for yeast metabolic engineering. FEMS Yeast Res. 2014, 10.1111/567-364.12185.
211. Johnson T.A., Sohn J., Inman W.D., Estee S.A., Loveridge S.T., Vervoort H.C., et al. Natural product libraries to accelerate the high-throughput discovery of therapeutic leads. J. Nat. Prod. 2011, 74:2545-2555.
212. Jones W.P., Kinghorn A.D. Extraction of plant secondary metabolites. Methods Mol. Biol. 2012, 864:341-366.
213. Jones M., Pulman J., Walker T. Drugs from daffodils. Chem. Ind. 2011, 18-20.
214. Jones S.B., Simmons B., Mastracchio A., MacMillan D.W.C. Collective synthesis of natural products by means of organocascade catalysis. Nature 2011, 475:183-188.
215. Jørgensen L., McKerrall S.J., Kuttruff C.A., Ungeheuer F., Felding J., Baran P.S. 14-Step synthesis of (+)-ingenol from (+)-3-carene. Science 2013, 341:878-882.
216. Joshi K.C., Singh P., Pardasani R., Singh G. Quinones and other constituents from Haplophragma adenophyllum. Planta Med. 1979, 37:60-63.
217. Junio H.A., Sy-Cordero A.A., Ettefagh K.A., Burns J.T., Micko K.T., Graf T.N., et al. Synergy-directed fractionation of botanical medicines: a case study with goldenseal (Hydrastis canadensis). J. Nat. Prod. 2011, 74:1621-1629.
218. Kada T., Kaneko K., Matsuzaki S., Matsuzaki T., Hora Y. Detection and chemical identification of natural bio-antimutagens: a case of the green tea factor. Mutat. Res. 1985, 150:127-132.
219. Kaga H., Miura M., Orito K. A facile procedure for synthesis of capsaicin. J. Org. Chem. 1989, 54:3477-3478.
220. Kaiser H. Von der Pflanze zur Chemie - Die Frühgeschichte der "Rheumamittel". Z. Rheumatol. 2008, 67:252-262.
221. Kalidindi S., Jeong W.B., Schall A., Bandichhor R., Nosse B., Reiser O. Enantioselective synthesis of arglabin. Angew. Chem. Int. Ed. Engl. 2007, 46:6361-6363.
222. Kamleh A., Barrett M.P., Wildridge D., Burchmore R.J., Scheltema R.A., Watson D.G. Metabolomic profiling using Orbitrap Fourier transform mass spectrometry with hydrophilic interaction chromatography: a method with wide applicability to analysis of biomolecules. Rapid Commun. Mass Spectrom. 2008, 22:1912-1918.
223. Kanokwaree K., Doran P.M. Effect of inoculum size on growth of Atropa belladonna hairy roots in shake flasks. J. Ferment. Bioeng. 1997, 84:378-381.
224. Kaserer T., Temml V., Schuster D. Polypharmacology and adverse bioactivty profiles predict potential toxicity and drug-related ADRs. Predictive ADMET 2014, 23-45. John Wiley & Sons, Hoboken, New Jersey. J. Wang, L. Urban (Eds.).
225. Kawaguchi H., Hirakawa K., Miyauchi K., Koike K., Ohno Y., Sakamoto A. Pattern recognition analysis of proton nuclear magnetic resonance spectra of brain tissue extracts from rats anesthetized with propofol or isoflurane. PLoS One 2010, 5:e11172.
226. Keasling J.D., Mendoza A., Baran P.S. Synthesis: a constructive debate. Nature 2012, 492:188-189.
227. Keerthi D., Geethu C., Nair R.A., Pillai P. Metabolic profiling of Zingiber zerumbet following Pythium myriotylum infection: investigations on the defensive role of the principal secondary metabolite, zerumbone. Appl. Biochem. Biotechnol. 2014, 172:2593-2603.
228. Kervinen J., Crysler C., Bayoumy S., Abad M.C., Spurlino J., Deckman I., et al. Potency variation of small-molecule chymase inhibitors across species. Biochem. Pharmacol. 2010, 80:1033-1041.
229. Ketting R.F. The many faces of RNAi. Dev. Cell 2011, 20:148-161.
230. Khafagi I.K., Dewedar A. The efficiency of random versus ethno-directed research in the evaluation of Sinai medicinal plants for bioactive compounds. J. Ethnopharmacol. 2000, 71:365-376.
231. Kim H., Nagaki A., Yoshida J.-i. A flow-microreactor approach to protecting-group-free synthesis using organolithium compounds. Nat. Commun. 2011, 2. (1264/1-/6).
232. Kinghorn A.D., Pan L., Fletcher J.N., Chai H. The relevance of higher plants in lead compound discovery programs. J. Nat. Prod. 2011, 74:1539-1555.
233. Kingston D.G. Modern natural products drug discovery and its relevance to biodiversity conservation. J. Nat. Prod. 2011, 74:496-511.
234. Kirakosyan A., Cseke L.J., Kaufman P.B. The use of plant cell biotechnology for the production of phytochemicals. Recent Advances in Plant Biotechnology 2009, 15-33.
235. Kirby J., Nishimoto M., Park J.G., Withers S.T., Nowroozi F., Behrendt D., et al. Cloning of casbene and neocembrene synthases from Euphorbiaceae plants and expression in Saccharomyces cerevisiae. Phytochemistry 2010, 71:1466-1473.
236. Kjer J., Debbab A., Aly A.H., Proksch P. Methods for isolation of marine-derived endophytic fungi and their bioactive secondary products. Nat. Protoc. 2010, 5:479-490.
237. Klayman D.L. Qinghaosu (artemisinin): an antimalarial drug from China. Science 1985, 228:1049-1055.
238. Klayman D.L., Lin A.J., Acton N., Scovill J.P., Hoch J.M., Milhous W.K., et al. Isolation of artemisinin (qinghaosu) from Artemisia annua growing in the United States. J. Nat. Prod. 1984, 47:715-717.
239. Klebe G. Wirkstoffdesign: Entwurf und Wirkung von Arzneistoffen 2009, 2nd ed.
240. Koehn F.E., Carter G.T. The evolving role of natural products in drug discovery. Nat. Rev. Drug Discov. 2005, 4:206-220.
241. Kola I., Landis J. Can the pharmaceutical industry reduce attrition rates?. Nat. Rev. Drug Discov. 2004, 3:711-715.
242. Kolewe M.E., Gaurav V., Roberts S.C. Pharmaceutically active natural product synthesis and supply via plant cell culture technology. Mol. Pharm. 2008, 5:243-256.
243. Kong D.-X., Li X.-J., Zhang H.-Y. Where is the hope for drug discovery? Let history tell the future. Drug Discov. Today 2009, 14:115-119.
244. Kong J., Yang Y., Wang W., Cheng K., Zhu P. Artemisinic acid: a promising molecule potentially suitable for the semi-synthesis of artemisinin. RSC Adv. 2013, 3:7622-7641.
245. Kovacs K., Zhang L., Linforth R.S., Whittaker B., Hayes C.J., Fray R.G. Redirection of carotenoid metabolism for the efficient production of taxadiene [taxa-4(5),11(12)-diene] in transgenic tomato fruit. Transgenic Res. 2007, 16:121-126.
246. Krief S., Martin M.T., Grellier P., Kasenene J., Sevenet T. Novel antimalarial compounds isolated in a survey of self-medicative behavior of wild chimpanzees in Uganda. Antimicrob. Agents Chemother. 2004, 48:3196-3199.
247. Krief S., Huffman M.A., Sevenet T., Hladik C.M., Grellier P., Loiseau P.M., et al. Bioactive properties of plant species ingested by chimpanzees (Pan troglodytes schweinfurthii) in the Kibale National Park, Uganda. Am. J. Primatol. 2006, 68:51-71.
248. Kruse P.R. Geschichte der Pharmazie. Vol. II: Von der Frühen Neuzeit bis zur Gegenwart - by Rudolf Schmitz. Centaurus 2007, 49:182-183.
249. Küenburg B., Czollner L., Fröhlich J., Jordis U. Development of a pilot scale process for the anti-Alzheimer drug (-)-galanthamine using large-scale phenolic oxidative coupling and crystallisation-induced chiral conversion. Org. Process Res. Dev. 1999, 3:425-431.
250. Kunwar R.M., Uprety Y., Burlakoti C., Chowdhary C.L., Bussmann R.W. Indigenous use and ethnopharmacology of medicinal plants in far-west Nepal. Ethnobot. Res. Appl. 2009, 7:5-28.
251. Kurin E., Atanasov A.G., Donath O., Heiss E.H., Dirsch V.M., Nagy M. Synergy study of the inhibitory potential of red wine polyphenols on vascular smooth muscle cell proliferation. Planta Med. 2012, 78:772-778.
252. Kuttruff C.A., Eastgate M.D., Baran P.S. Natural product synthesis in the age of scalability. Nat. Prod. Rep. 2014, 31:419-432.
253. Kuwajima I., Tanino K. Total synthesis of ingenol. Chem. Rev. 2005, 105:4661-4670.
254. Kuzuyama T., Seto H. Diversity of the biosynthesis of the isoprene units. Nat. Prod. Rep. 2003, 20:171-183.
255. Ladurner A., Schmitt C.A., Schachner D., Atanasov A.G., Werner E.R., Dirsch V.M., et al. Ascorbate stimulates endothelial nitric oxide synthase enzyme activity by rapid modulation of its phosphorylation status. Free Radic. Biol. Med. 2012, 52:2082-2090.
256. Laird T. How to minimise scale up difficulties. Chem. Ind. Dig. 2010, 23:51-56.
257. Langcake P., Pryce R. The production of resveratrol by Vitis vinifera and other members of the Vitaceae as a response to infection or injury. Physiol. Plant Pathol. 1976, 9:77-86.
258. Lange B.M., Ahkami A. Metabolic engineering of plant monoterpenes, sesquiterpenes and diterpenes - current status and future opportunities. Plant Biotechnol. J. 2013, 11:169-196.
259. Larsen M.M., Adsersen A., Davis A.P., Lledó M.D., Jäger A.K., Rønsted N. Using a phylogenetic approach to selection of target plants in drug discovery of acetylcholinesterase inhibiting alkaloids in Amaryllidaceae tribe Galantheae. Biochem. Syst. Ecol. 2010, 38:1026-1034.
260. Larsen M.J., Larsen S.D., Fribley A., Grembecka J., Homan K., Mapp A., et al. The role of HTS in drug discovery at the University of Michigan. Comb. Chem. High Throughput Screen. 2014, 17:210-230.
261. Larsson J., Gottfries J., Muresan S., Backlund A. ChemGPS-NP: tuned for navigation in biologically relevant chemical space. J. Nat. Prod. 2007, 70:789-794.
262. Lee J., Bogyo M. Target deconvolution techniques in modern phenotypic profiling. Curr. Opin. Chem. Biol. 2013, 17:118-126.
263. Lee M.L., Schneider G. Scaffold architecture and pharmacophoric properties of natural products and trade drugs: application in the design of natural product-based combinatorial libraries. J. Comb. Chem. 2001, 3:284-289.
264. Lee J.C., S-j Jin, Cha J.K. Total synthesis of colchicine. α-Methoxy-substituted oxyallyl [4 + 3] cycloaddition approach. J. Org. Chem. 1998, 63:2804-2805.
265. Lee E.K., Jin Y.W., Park J.H., Yoo Y.M., Hong S.M., Amir R., et al. Cultured cambial meristematic cells as a source of plant natural products. Nat. Biotechnol. 2010, 28:1213-1217.
266. Lee J.A., Uhlik M.T., Moxham C.M., Tomandl D., Sall D.J. Modern phenotypic drug discovery is a viable, neoclassic pharma strategy. J. Med. Chem. 2012, 55:4527-4538.
267. Leete E., Nemeth P.E. The biogenesis of the alkaloids of Colchicum. I. The incorporation of phenylalanine into colchicine1. J. Am. Chem. Soc. 1960, 82:6055-6057.
268. Leonti M. The future is written: impact of scripts on the cognition, selection, knowledge and transmission of medicinal plant use and its implications for ethnobotany and ethnopharmacology. J. Ethnopharmacol. 2011, 134:542-555.
269. Levesque F., Seeberger P.H. Continuous-flow synthesis of the anti-malaria drug artemisinin. Angew. Chem. Int. Ed. Engl. 2012, 51:1706-1709. (S/1-S/20).
270. Lewis W.H. Medical botany. Plants Affecting Human Health 2003, John Wiley & Sons, Hoboken New Jersey, USA.
271. Ley S.V. On being green: can flow chemistry help?. Chem. Rec. 2012, 12:378-390.
272. Li Y., Pfeifer B.A. Heterologous production of plant-derived isoprenoid products in microbes and the application of metabolic engineering and synthetic biology. Curr. Opin. Plant Biol. 2014, 19:8-13.
273. Li J.W., Vederas J.C. Drug discovery and natural products: end of an era or an endless frontier?. Science 2009, 325:161-165.
274. Li Q., Chen T., Wang Y., Bryant S.H. PubChem as a public resource for drug discovery. Drug Discov. Today 2010, 15:1052-1057.
275. Li H., Wang X., Hong B., Lei X. Collective synthesis of lycopodium alkaloids and tautomer locking strategy for the total synthesis of (-)-lycojapodine A. J. Org. Chem. 2013, 78:800-821.
276. Liang X., Grue-Soerensen G., Petersen A.K., Hogberg T. Semisynthesis of ingenol 3-angelate (PEP005): efficient stereoconservative angeloylation of alcohols. Synlett 2012, 23:2647-2652.
277. Liljegren D. Glucosylation of solasodine by extracts from Solanum laciniatum. Phytochemistry 1971, 10:3061-3064.
278. Ling Y., Chen M., Wang K., Sun Z., Li Z., Wu B., et al. Systematic screening and characterization of the major bioactive components of Poria cocos and their metabolites in rats by LC-ESI-MS(n). Biomed. Chromatogr. 2012, 26:1109-1117.
279. Lipinski C., Hopkins A. Navigating chemical space for biology and medicine. Nature 2004, 432:855-861.
280. Liu Z. Preparation of botanical samples for biomedical research. Endocr. Metab. Immune Disord. Drug Targets 2008, 8:112-121.
281. Liu Y., Wang M.W. Botanical drugs: challenges and opportunities: contribution to Linnaeus Memorial Symposium 2007. Life Sci. 2008, 82:445-449.
282. Liu S., Hsieh D., Yang Y.L., Xu Z., Peto C., Jablons D.M., et al. Coumestrol from the national cancer Institute's natural product library is a novel inhibitor of protein kinase CK2. BMC Pharmacol. Toxicol. 2013, 14:36.
283. Lo T.M., Teo W.S., Ling H., Chen B., Kang A., Chang M.W. Microbial engineering strategies to improve cell viability for biochemical production. Biotechnol. Adv. 2013, 31:903-914.
284. Lubbe A., Verpoorte R. Cultivation of medicinal and aromatic plants for specialty industrial materials. Ind. Crop. Prod. 2011, 34:785-801.
285. Luo J., Chuang T., Cheung J., Quan J., Tsai J., Sullivan C., et al. Masoprocol (nordihydroguaiaretic acid): a new antihyperglycemic agent isolated from the creosote bush (Larrea tridentata). Eur. J. Pharmacol. 1998, 346:77-79.
286. Luo Z., Liu Y., Zhao B., Tang M., Dong H., Zhang L., et al. Ex vivo and in situ approaches used to study intestinal absorption. J. Pharmacol. Toxicol. Methods 2013, 68:208-216.
287. Mabona U., Viljoen A., Shikanga E., Marston A., Van Vuuren S. Antimicrobial activity of southern African medicinal plants with dermatological relevance: from an ethnopharmacological screening approach, to combination studies and the isolation of a bioactive compound. J. Ethnopharmacol. 2013, 148:45-55.
288. Maclean I.M., Wilson R.J. Recent ecological responses to climate change support predictions of high extinction risk. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:12337-12342.
289. Maes J., Verlooy L., Buenafe O.E., de Witte P.A., Esguerra C.V., Crawford A.D. Evaluation of 14 organic solvents and carriers for screening applications in zebrafish embryos and larvae. PLoS One 2012, 7:e43850.
290. Makky K., Duvnjak P., Pramanik K., Ramchandran R., Mayer A.N. A whole-animal microplate assay for metabolic rate using zebrafish. J. Biomol. Screen. 2008, 13:960-967.
291. Malik S., Cusidó R.M., Mirjalili M.H., Moyano E., Palazón J., Bonfill M. Production of the anticancer drug taxol in Taxus baccata suspension cultures: A review. Process Biochem. 2011, 46:23-34.
292. Mans D.R., da Rocha A.B., Schwartsmann G. Anti-cancer drug discovery and development in Brazil: targeted plant collection as a rational strategy to acquire candidate anti-cancer compounds. Oncologist 2000, 5:185-198.
293. Mao Q., Yang J., Cui X.M., Li J.J., Qi Y.T., Zhang P.H., et al. Target separation of a new anti-tumor saponin and metabolic profiling of leaves of Panax notoginseng by liquid chromatography with eletrospray ionization quadrupole time-of-flight mass spectrometry. J. Pharm. Biomed. Anal. 2012, 59:67-77.
294. Maree J., Kamatou G., Gibbons S., Viljoen A., Van Vuuren S. The application of GC-MS combined with chemometrics for the identification of antimicrobial compounds from selected commercial essential oils. Chemom. Intell. Lab. 2014, 130:172-181.
295. Marienhagen J., Bott M. Metabolic engineering of microorganisms for the synthesis of plant natural products. J. Biotechnol. 2013, 163:166-178.
296. Mashkovsky M.D., Kruglikova-Lvova R.P. On the pharmacology of the new alkaloid galantamine. Farmacol. Toxicol. (Mosk.) 1951, 14:27-30. (in Russian).
297. McKerrall S.J., Jørgensen L., Kuttruff C.A., Ungeheuer F., Baran P.S. Development of a concise synthesis of (+)-ingenol. J. Am. Chem. Soc. 2014, 136:5799-5810.
298. Mehrotra S., Goel M.K., Kukreja A.K., Mishra B.N. Efficiency of liquid culture systems over conventional micropropagation: A progress towards commercialization. Afr. J. Biotechnol. 2007, 6:1484-1492.
299. Miettinen K., Dong L., Navrot N., Schneider T., Burlat V., Pollier J., et al. The seco-iridoid pathway from Catharanthus roseus. Nat. Commun. 2014, 5:3606. 10.1038/ncomms4606.
300. Miller J.C., Tan S., Qiao G., Barlow K.A., Wang J., Xia D.F., et al. A TALE nuclease architecture for efficient genome editing. Nat. Biotechnol. 2011, 29:143-148.
301. Minic J., Sautel M., Salesse R., Pajot-Augy E. Yeast system as a screening tool for pharmacological assessment of g protein coupled receptors. Curr. Med. Chem. 2005, 12:961-969.
302. Miralpeix B., Rischer H., Hakkinen S.T., Ritala A., Seppanen-Laakso T., Oksman-Caldentey K.M., et al. Metabolic engineering of plant secondary products: which way forward?. Curr. Pharm. Des. 2013, 19:5622-5639.
303. Modarai M., Yang M., Suter A., Kortenkamp A., Heinrich M. Metabolomic profiling of liquid Echinacea medicinal products with in vitro inhibitory effects on cytochrome P450 3A4 (CYP3A4). Planta Med. 2010, 76:378-385.
304. Moerman D.E. Native North American food and medicinal plants: epistemological considerations. Plants for Food and Medicine 1998, 69-74. Royal Botanic Gardens, Kew: Richmond, UK. N.L. Etkin, D.R. Harris, H.D.V. Prendergast, P.J. Houghton (Eds.).
305. Moon J.K., Shibamoto T. Antioxidant assays for plant and food components. J. Agric. Food Chem. 2009, 57:1655-1666.
306. Mora-Pale M., Sanchez-Rodriguez S.P., Linhardt R.J., Dordick J.S., Koffas M.A. Metabolic engineering and in vitro biosynthesis of phytochemicals and non-natural analogues. Plant Sci. 2013, 210:10-24.
307. Mora-Pale M., S-RSP, Linhardt R.J., Dordick J.S., Koffas M.A.G. Biochemical strategies for enhancing the in vitro production of natural products with pharmaceutical potential. Curr. Opin. Biotechnol. 2014, 25:86-94.
308. Murthy H.N., Lee E.J., Paek K.Y. Production of secondary metabolites from cell and organ cultures: Strategies and approaches for biomass improvement and metabolite accumulation. Plant Cell Tissue Organ Cult. 2014, 118:1-16.
309. Nacoulma A.P., Vandeputte O.M., De Lorenzi M., Jaziri M.E., Duez P. Metabolomic-based study of the leafy gall, the ecological niche of the phytopathogen rhodococcus fascians, as a potential source of bioactive compounds. Int. J. Mol. Sci. 2013, 14:12533-12549.
310. Namdeo A.G. Plant cell elicitation for production of secondary metabolites: a review. Phcog. Rev. 2007, 1:69-79.
311. Ndhlala A.R., Aderogba M.A., Ncube B., Van Staden J. Anti-oxidative and cholinesterase inhibitory effects of leaf extracts and their isolated compounds from two closely related Croton species. Molecules 2013, 18:1916-1932.
312. Newman D.J., Cragg G.M. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod. 2012, 75:311-335.
313. Ngo L.T., Okogun J.I., Folk W.R. 21st century natural product research and drug development and traditional medicines. Nat. Prod. Rep. 2013, 30:584-592.
314. Nicolaou K.C. Organic synthesis: the art and science of replicating the molecules of living nature and creating others like them in the laboratory. Proc. R. Soc. A 2014, 470. (470:20130690/1-/17).
315. Nicolaou K.C., Yang Z., Liu J.J., Ueno H., Nantermet P.G., Guy R.K., et al. Total synthesis of taxol. Nature 1994, 367:630-634.
316. Nicolaou K.C., Sorensen E.J., Winssinger N. The art and science of organic and natural products synthesis. J. Chem. Educ. 1998, 75:1226-1258.
317. Nielsen A.L., Kristensen L.H., Stephansen K.B., Kristensen J.B.L., Helgstrand C., Lees M., et al. Identification of catechols as histone-lysine demethylase inhibitors. FEBS Lett. 2012, 586:1190-1194.
318. Nievergelt A., Huonker P., Schoop R., Altmann K.H., Gertsch J. Identification of serotonin 5-HT1A receptor partial agonists in ginger. Bioorg. Med. Chem. 2010, 18:3345-3351.
319. Ningthoujam S.S., Talukdar A.D., Potsangbam K.S., Choudhury M.D. Challenges in developing medicinal plant databases for sharing ethnopharmacological knowledge. J. Ethnopharmacol. 2012, 141:9-32.
320. Nitteranon V., Zhang G., Darien B.J., Parkin K. Isolation and synergism of in vitro anti-inflammatory and quinone reductase (QR) inducing agents from the fruits of Morinda citrifolia (noni). Food Res. Int. 2011, 44:2271-2277.
321. Noreen Y., el-Seedi H., Perera P., Bohlin L. Two new isoflavones from Ceiba pentandra and their effect on cyclooxygenase-catalyzed prostaglandin biosynthesis. J. Nat. Prod. 1998, 61:8-12.
322. Obbo C.J.D., Makanga B., Mulholland D.A., Coombes P.H., Brun R. Antiprotozoal activity of Khaya anthotheca, (Welv.) C.D.C. a plant used by chimpanzees for self-medication. J. Ethnopharmacol. 2013, 147:220-223.
323. Obembe O.O., Popoola J.O., Leelavathi S., Reddy S.V. Advances in plant molecular farming. Biotechnol. Adv. 2011, 29:210-222.
324. Oliva M.J. Sharing the benefits of biodiversity: a new international protocol and its implications for research and development. Planta Med. 2011, 77:1221-1227.
325. Oliveira D.R., Leitão G.G., Coelho T.S., Silva PEAd, Lourenço M.C.S., Leitão S.G. Ethnopharmacological versus random plant selection methods for the evaluation of the antimycobacterial activity. Rev. Bras. Farmacogn. 2011, 21:793-806.
326. Ongley S.E., Bian X., Neilan B.A., Muller R. Recent advances in the heterologous expression of microbial natural product biosynthetic pathways. Nat. Prod. Rep. 2013, 30:1121-1138.
327. Ono N.N., Tian L. The multiplicity of hairy root cultures: prolific possibilities. Plant Sci. 2011, 180:439-446.
328. Oprea T.I., Gottfries J. Chemography: the art of navigating in chemical space. J. Comb. Chem. 2001, 3:157-166.
329. O'Reilly L.P., Luke C.J., Perlmutter D.H., Silverman G.A., Pak S.C. C. elegans in high-throughput drug discovery. Adv. Drug Deliv. Rev. 2014, 69-70:247-253.
330. Orlikova B., Schumacher M., Juncker T., Yan C.C., Inayat-Hussain S.H., Hajjouli S., et al. Styryl-lactone goniothalamin inhibits TNF-alpha-induced NF-kappaB activation. Food Chem. Toxicol. 2013, 59:572-578.
331. Ortholand J.Y., Ganesan A. Natural products and combinatorial chemistry: back to the future. Curr. Opin. Chem. Biol. 2004, 8:271-280.
332. Paddon C.J., Keasling J.D. Semi-synthetic artemisinin: a model for the use of synthetic biology in pharmaceutical development. Nat. Rev. Microbiol. 2014, 12:355-367.
333. Paddon C.J., Westfall P.J., Pitera D.J., Benjamin K., Fisher K., McPhee D., et al. High-level semi-synthetic production of the potent antimalarial artemisinin. Nature 2013, 496:528-532.
334. Pandey R., Krishnasamy V., Kumaravadivel N., Rajamani K. Establishment of hairy root culture and production of secondary metabolites in Coleus (Coleus forskohlii). J. Med. Plant Res. 2014, 8:58-62.
335. Pantev A., Ivancheva S., Staneva L., Serkedjieva J. Biologically active constituents of a polyphenol extract from Geranium sanguineum L. with anti-influenza activity. Z. Naturforsch. C 2006, 61:508-516.
336. Parasuraman S. Toxicological screening. J. Pharmacol. Pharmacother. 2011, 2:74-79.
337. Park J.-Y., Park C.-M., Kim J.-J., Noh K.-H., Cho C.-W., Song Y.-S. The protective effect of chlorophyll a against oxidative stress and inflammatory processes in LPS-stimulated macrophages. Food Sci. Biotechnol. 2007, 16:205-211.
338. Pastre J.C., Browne D.L., Ley S.V. Flow chemistry syntheses of natural products. Chem. Soc. Rev. 2013, 42:8849-8869.
339. Patel R.N., Banerjee A., Ko R.Y., Howell J.M., Li W.-S., Comezoglu F.T., et al. Enzymic preparation of (3R-cis)-3-(acetyloxy)-4-phenyl-2-azetidinone: a taxol side-chain synthon. Biotechnol. Appl. Biochem. 1994, 20:23-33.
340. Paterson I., Anderson E.A. Chemistry. The renaissance of natural products as drug candidates. Science 2005, 310:451-453.
341. Pathmasiri W., el-Seedi H.R., Han X., Janson J.C., Huss U., Bohlin L. Aryl ketones from Acronychia pedunculata with cyclooxygenase-2 inhibitory effects. Chem. Biodivers. 2005, 2:463-469.
342. Patwardhan B. Ethnopharmacology and drug discovery. J. Ethnopharmacol. 2005, 100:50-52.
343. Patwardhan B., Vaidya A.D. Natural products drug discovery: accelerating the clinical candidate development using reverse pharmacology approaches. Indian J. Exp. Biol. 2010, 48:220-227.
344. Pellegatti M. Dogs and monkeys in preclinical drug development: the challenge of reducing and replacing. Expert Opin. Drug Metab. Toxicol. 2013, 9:1171-1180.
345. Pence V.C. Evaluating costs for the in vitro propagation and preservation of endangered plants. In Vitro Cell Dev. Biol. Plant 2011, 47:176-187.
346. Perkin A.G., Newbury F.G. LXXIX. - the colouring matters contained in dyer's broom (Genista tinctoria) and heather (Calluna vulgaris). J. Chem. Soc. Trans. 1899, 75:830-839.
347. Peters R.J., Crouteau R.B. Metabolic engineering of plant secondary metabolism. Handbook of Plant Biotechology 2004, 1:609-629. John Wiley & Sons Ltd, Chichester, England. P. Christou, H. Klee (Eds.).
348. Petrzilka T., Haefliger W., Sikemeier C. Synthesis of hashish components. IV. Helv. Chim. Acta 1969, 52:1102-1134.
349. Pfisterer P.H., Shen C., Nikolovska-Coleska Z., Schyschka L., Schuster D., Rudy A., et al. In silico discovery of acylated flavonol monorhamnosides from Eriobotrya japonica as natural, small-molecular weight inhibitors of XIAP BIR3. Bioorg. Med. Chem. 2011, 19:1002-1009.
350. Picker P., Vogl S., McKinnon R., Mihaly-Bison J., Binder M., Atanasov A.G., et al. Plant extracts in cell-based anti-inflammatory assays - pitfalls and considerations related to removal of activity masking bulk components. Phytochem. Lett. 2014, 10:xli-xlvii. 10.1016/j.phytol.2014.04.001.
351. Pluskal T., Castillo S., Villar-Briones A., Oresic M. MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinf. 2010, 11:395-399.
352. Potterat O., Hamburger M. Natural products in drug discovery - concepts and approaches for tracking bioactivity. Curr. Org. Chem. 2006, 10:899-920.
353. Powell R.G., Rogovin S.P., Smith C.R. Isolation of antitumor alkaloids from Cephalotaxus harringtonia. Ind. Eng. Chem. Prod. Res. Dev. 1974, 13:129-132.
354. Prasain J.K., Stefanowicz P., Kiyota T., Habeichi F., Konishi Y. Taxines from the needles of Taxus wallichiana. Phytochemistry 2001, 58:1167-1170.
355. Pulak R. Techniques for analysis, sorting, and dispensing of C. elegans on the COPAS flow-sorting system. Methods Mol. Biol. 2006, 351:275-286.
356. Qiao X., Ye M., Xiang C., Wang Q., Liu C.F., Miao W.J., et al. Analytical strategy to reveal the in vivo process of multi-component herbal medicine: a pharmacokinetic study of licorice using liquid chromatography coupled with triple quadrupole mass spectrometry. J. Chromatogr. A 2012, 1258:84-93.
357. Ramakrishna A., Ravishankar G.A. Influence of abiotic stress signals on secondary metabolites in plants. Plant Signal. Behav. 2011, 6:1720-1731.
358. Ramasamy D., Saraswathy A. Vitiquinolone - a quinolone alkaloid from Hibiscus vitifolius Linn. Food Chem. 2014, 145:970-975.
359. Rao S.R., Ravishankar G.A. Plant cell cultures: chemical factories of secondary metabolites. Biotechnol. Adv. 2002, 20:101-153.
360. Rask-Andersen M., Almen M.S., Schioth H.B. Trends in the exploitation of novel drug targets. Nat. Rev. Drug Discov. 2011, 10:579-590.
361. Ratner M. Pfizer stakes a claim in plant cell-made biopharmaceuticals. Nat. Biotechnol. 2010, 28:107-108.
362. Read P.E. Micropropagation: past, present and future. Acta Hortic. 2007, 17-27.
363. Reed J.W., Hudlicky T. The quest for a practical synthesis of morphine alkaloids and their derivatives by chemoenzymatic methods. Acc. Chem. Res. 2015, 48:674-687.
364. Reuter S., Charlet J., Juncker T., Teiten M.H., Dicato M., Diederich M. Effect of curcumin on nuclear factor kappaB signaling pathways in human chronic myelogenous K562 leukemia cells. Ann. N. Y. Acad. Sci. 2009, 1171:436-447.
365. Riva E., Rencurosi A., Gagliardi S., Passarella D., Martinelli M. Synthesis of (+)-dumetorine and congeners by using flow chemistry technologies. Chemistry 2011, 17:6221-6226.
366. Roberts S., Kolewe M. Plant natural products from cultured multipotent cells. Nat. Biotechnol. 2010, 28:1175-1176.
367. Robertson A.L., Holmes G.R., Bojarczuk A.N., Burgon J., Loynes C.A., Chimen M., et al. A zebrafish compound screen reveals modulation of neutrophil reverse migration as an anti-inflammatory mechanism. Sci. Transl. Med. 2014, 6:225ra29.
368. Robinson R. Synthesis of tropinone. J. Chem. Soc. Trans. 1917, 111:762-768.
369. Rollinger J.M., Haupt S., Stuppner H., Langer T. Combining ethnopharmacology and virtual screening for lead structure discovery: COX-inhibitors as application example. J. Chem. Inf. Comput. Sci. 2004, 44:480-488.
370. Rollinger J.M., Stuppner H., Langer T. Virtual screening for the discovery of bioactive natural products. Prog. Drug Res. 2008, 65:213-249.
371. Rollinger J.M., Schuster D., Danzl B., Schwalger S., Markt P., Schmidtke M., et al. In silico target fishing for rationalized ligand discovery exemplified on constituents of Ruta graveolens. Planta Med. 2009, 75:195-204.
372. Ron M., Kajala K., Pauluzzi G., Wang D., Reynoso M.A., Zumstein K., et al. Hairy root transformation using Agrobacterium rhizogenes as a tool for exploring cell type-specific gene expression and function using tomato as a model. Plant Physiol. 2014, 166:455-469.
373. Rønsted N., Savolainen V., Mølgaard P., Jäger A.K. Phylogenetic selection of Narcissus species for drug discovery. Biochem. Syst. Ecol. 2008, 36:417-422.
374. Rosen J., Lovgren A., Kogej T., Muresan S., Gottfries J., Backlund A. ChemGPS-NP(Web): chemical space navigation online. J. Comput. Aided Mol. Des. 2009, 23:253-259.
375. Rout G.R., Samantaray S., Das P. In vitro manipulation and propagation of medicinal plants. Biotechnol. Adv. 2000, 18:91-120.
376. Sahu J., Sahu R.K. A review on low cost methods for in vitro micropropagation of plant through tissue culture technique. UK J. Pharm. Biosci. 2013, 1:38-41.
377. Sandasi M., Kamatou G.P., Viljoen A.M. An untargeted metabolomic approach in the chemotaxonomic assessment of two Salvia species as a potential source of alpha-bisabolol. Phytochemistry 2012, 84:94-101.
378. Sarasan V., Kite G.C., Sileshi G.W., Stevenson P.C. Applications of phytochemical and in vitro techniques for reducing over-harvesting of medicinal and pesticidal plants and generating income for the rural poor. Plant Cell Rep. 2011, 30:1163-1172.
379. Sasiela C.A., Stewart D.H., Kitagaki J., Safiran Y.J., Yang Y., Weissman A.M., et al. Identification of inhibitors for MDM2 ubiquitin ligase activity from natural product extracts by a novel high-throughput electrochemiluminescent screen. J. Biomol. Screen. 2008, 13:229-237.
380. Saslis-Lagoudakis C.H., Klitgaard B.B., Forest F., Francis L., Savolainen V., Williamson E.M., et al. The use of phylogeny to interpret cross-cultural patterns in plant use and guide medicinal plant discovery: an example from Pterocarpus (Leguminosae). PLoS One 2011, 6:e22275.
381. Saslis-Lagoudakis C.H., Savolainen V., Williamson E.M., Forest F., Wagstaff S.J., Baral S.R., et al. Phylogenies reveal predictive power of traditional medicine in bioprospecting. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:15835-15840.
382. Sathishkumar N., Karpagam V., Sathiyamoorthy S., Woo M.J., Kim Y.J., Yang D.C. Computer-aided identification of EGFR tyrosine kinase inhibitors using ginsenosides from Panax ginseng. Comput. Biol. Med. 2013, 43:786-797.
383. Sauerwein M., Yoshimatsu K., Shimomura K. Further approaches in the production of secondary metabolites by plant tissue cultures. Plant Tissue Cult. Lett. 1992, 9:1-9.
384. Scannell J.W., Blanckley A., Boldon H., Warrington B. Diagnosing the decline in pharmaceutical R&D efficiency. Nat. Rev. Drug Discov. 2012, 11:191-200.
385. Scheer N., Roland Wolf C. Xenobiotic receptor humanized mice and their utility. Drug Metab. Rev. 2013, 45:110-121.
386. Schenone M., Dancik V., Wagner B.K., Clemons P.A. Target identification and mechanism of action in chemical biology and drug discovery. Nat. Chem. Biol. 2013, 9:232-240.
387. Schiff P.B., Horwitz S.B. Taxol stabilizes microtubules in mouse fibroblast cells. Proc. Natl. Acad. Sci. U. S. A. 1980, 77:1561-1565.
388. Schiff P.B., Fant J., Horwitz S.B. Promotion of microtubule assembly in vitro by taxol. Nature 1979, 277:665-667.
389. Schippmann U., Leaman D., Cunningham A.B. A comparison of cultivation and wild collection of medicinal and aromatic plants under sustainability aspects. Medicinal and Aromatic Plants: Agricultural, Commercial, Ecological, Legal, Pharmacological and Social Aspects 2006, 75-95. Springer, Dordrecht. R.J. Bogers, CLE, D. Lange (Eds.).
390. Schmid I.I., Sattler I.I., Grabley S., Thiericke R. Natural products in high throughput screening: automated high-quality sample preparation. J. Biomol. Screen. 1999, 4:15-25.
391. Schmidt B., Ribnicky D.M., Poulev A., Logendra S., Cefalu W.T., Raskin I. A natural history of botanical therapeutics. Metabolism 2008, 57:S3-S9.
392. Schreiner C.E., Kumerz M., Gesslbauer J., Schachner D., Joa H., Erker T., et al. Resveratrol blocks Akt activation in angiotensin II- or EGF-stimulated vascular smooth muscle cells in a redox-independent manner. Cardiovasc. Res. 2011, 90:140-147.
393. Schuster D. 3D pharmacophores as tools for activity profiling. Drug Discov. Today Technol. 2010, 7:e205-e211.
394. Schuster D., Laggner C., Langer T. Why drugs fail - a study on side effects in new chemical entities. Curr. Pharm. Des. 2005, 11:3545-3559.
395. Schwaiberger A.V., Heiss E.H., Cabaravdic M., Oberan T., Zaujec J., Schachner D., et al. Indirubin-3'-monoxime blocks vascular smooth muscle cell proliferation by inhibition of signal transducer and activator of transcription 3 signaling and reduces neointima formation in vivo. Arterioscler. Thromb. Vasc. Biol. 2010, 30:2475-2481.
396. Sertürner F.W. Über das Morphium, eine neue salzfähige Grundlage, und die Mekonsäure, als Hauptbestandteile des Opiums. Ann. Phys. 1817, 25:56-90.
397. Shaneyfelt M.E., Burke A.D., Graff J.W., Jutila M.A., Hardy M.E. Natural products that reduce rotavirus infectivity identified by a cell-based moderate-throughput screening assay. Virol. J. 2006, 3:68.
398. Sharma M., Sharma A., Kumar A., Basu S.K. Enhancement of secondary metabolites in cultured plant cells through stress stimulus. Am. J. Plant Physiol. 2011, 6:50-71.
399. Sheldon R.A. Organic synthesis - past, present and future. Chem. Ind. 1992, 903-906.
400. Sheldon R.A. The E Factor: fifteen years on. Green Chem. 2007, 9:1273-1283.
401. Shendure J., Ji H. Next-generation DNA sequencing. Nat. Biotechnol. 2008, 26:1135-1145.
402. Shilpa K., Varun K., Lakshmi B.S. An alternate method of natural drug production: eliciting secondary metabolite production using plant cell culture. J. Plant Sci. 2010, 5:222-247.
403. Siahsar B., Rahimi M., Tavassoli A., Raissi A. Application of biotechnology in production of medicinal plants. Am. Eur. J. Agric. Environ. Sci. 2011, 11:439-444.
404. Siddiqui M.S., Thodey K., Trenchard I., Smolke C.D. Advancing secondary metabolite biosynthesis in yeast with synthetic biology tools. FEMS Yeast Res. 2012, 12:144-170.
405. Siriwatanametanon N., Heinrich M. The Thai medicinal plant Gynura pseudochina var. hispida: chemical composition and in vitro NF-kappaB inhibitory activity. Nat. Prod. Commun. 2011, 6:627-630.
406. Smith C.A., Want E.J., O'Maille G., Abagyan R., Siuzdak G. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal. Chem. 2006, 78:779-787.
407. Sneader W. Drug Discovery: A History 2005, Wiley.
408. Soejarto D.D., Gyllenhaal C., Fong H.H., Xuan L.T., Hiep N.T., Hung N.V., et al. The UIC ICBG (University of Illinois at Chicago International Cooperative Biodiversity Group) Memorandum of Agreement: a model of benefit-sharing arrangement in natural products drug discovery and development. J. Nat. Prod. 2004, 67:294-299.
409. Song M.C., Kim E.J., Kim E., Rathwell K., Nam S.J., Yoon Y.J. Microbial biosynthesis of medicinally important plant secondary metabolites. Nat. Prod. Rep. 2014, 31:1497-1509.
410. Spjut R. Limitations of a random screen: search for new anticancer drugs in higher plants. Econ. Bot. 1985, 39:266-288.
411. Stahura F.L., Godden J.W., Xue L., Bajorath J. Distinguishing between natural products and synthetic molecules by descriptor Shannon entropy analysis and binary QSAR calculations. J. Chem. Inf. Comput. Sci. 2000, 40:1245-1252.
412. Staniek A., Bouwmeester H., Fraser P.D., Kayser O., Martens S., Tissier A., et al. Natural products - learning chemistry from plants. Biotechnol. J. 2014, 9:326-336.
413. Steindl T.M., Schuster D., Laggner C., Langer T. Parallel screening: a novel concept in pharmacophore modeling and virtual screening. J. Chem. Inf. Model. 2006, 46:2146-2157.
414. Steindl T.M., Schuster D., Laggner C., Chuang K., Hoffmann R.D., Langer T. Parallel screening and activity profiling with HIV protease inhibitor pharmacophore models. J. Chem. Inf. Model. 2007, 47:563-571.
415. Stitt E.H., Simmons M.J.H. Scale-up of chemical reactions. Process Understanding 2011, 155-198. Wiley-VCH, Weinheim. I. Houson (Ed.).
416. Su Y.F., Zhang Z.X., Guo C.Y., Guo D.A. A nobel cyanogenic glycoside from Semiaquilegia adoxoides. J. Asian Nat. Prod. Res. 2005, 7:171-174.
417. Swindle M.M., Makin A., Herron A.J., Clubb F.J., Frazier K.S. Swine as models in biomedical research and toxicology testing. Vet. Pathol. 2012, 49:344-356.
418. Swinney D.C., Anthony J. How were new medicines discovered?. Nat. Rev. Drug Discov. 2011, 10:507-519.
419. Tafesh A., Najami N., Jadoun J., Halahlih F., Riepl H., Azaizeh H. Synergistic antibacterial effects of polyphenolic compounds from olive mill wastewater. Evid. Based Complement. Alternat. Med. 2011, 2011:431021.
420. Takenaka T. Classical vs reverse pharmacology in drug discovery. BJU Int. 2001, 88(Suppl. 2):7-10. (discussion 49-50).
421. Tan G.T., Pezzuto J.M., Kinghorn A.D., Hughes S.H. Evaluation of natural products as inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase. J. Nat. Prod. 1991, 54:143-154.
422. Tasheva K., Kosturkova G. Role of biotechnology for protection of endangered medicinal plants. Environmental Biotechnology - New Approaches and Prospective Applications 2013, InTech. M. Petre (Ed.).
423. Tawfike A.F., Viegelmann C., Edrada-Ebel R. Metabolomics and dereplication strategies in natural products. Methods Mol. Biol. 2013, 1055:227-244.
424. Teicher B.A. In vivo/ex vivo and in situ assays used in cancer research: a brief review. Toxicol. Pathol. 2009, 37:114-122.
425. Temml V., Kuehnl S., Schuster D., Schwaiger S., Stuppner H., Fuchs D. Interaction of Carthamus tinctorius lignan arctigenin with the binding site of tryptophan-degrading enzyme indoleamine 2,3-dioxygenase. FEBS Open Bio 2013, 3:450-452.
426. Thomas C.D., Cameron A., Green R.E., Bakkenes M., Beaumont L.J., Collingham Y.C., et al. Extinction risk from climate change. Nature 2004, 427:145-148.
427. Thoppil R.J., Harlev E., Mandal A., Nevo E., Bishayee A. Antitumor activities of extracts from selected desert plants against HepG2 human hepatocellular carcinoma cells. Pharm. Biol. 2013, 51:668-674.
428. Toh C., Lee T., Kiang A. The pharmacological actions of capsaicin and analogues. Br. J. Pharmacol. Chemother. 1955, 10:175-182.
429. Tomas-Barberan F.A., Garcia-Villalba R., Gonzalez-Sarrias A., Selma M.V., Espin J.C. Ellagic acid metabolism by human gut microbiota: consistent observation of three urolithin phenotypes in intervention trials, independent of food source, age, and health status. J. Agric. Food Chem. 2014, 62:6535-6538.
430. Tripathi L., Tripathi J.N. Role of biotechnology in medicinal plants. Trop. J. Pharm. Res. 2003, 2:243-253.
431. Trost B.M. The atom economy: a search for synthetic efficiency. Science 1991, 254:1471-1477.
432. 9-trans-tetrahydrocannabinol: stereocontrol via Mo-catalyzed asymmetric allylic alkylation reaction. Org. Lett. 2007, 9:861-863.
433. Tsakadze D., Abdusamatov A., Yunusov S.Y. Alkaloids of Galanthus caucasicus. Chem. Nat. Compd. 1969, 5:281-282.
434. Tu Y., Jeffries C., Ruan H., Nelson C., Smithson D., Shelat A.A., et al. Automated high-throughput system to fractionate plant natural products for drug discovery. J. Nat. Prod. 2010, 73:751-754.
435. Unschuld P.U. Medicine in China: A History of Pharmaceutics 1986, University of California Press.
436. Uzuner H., Bauer R., Fan T.P., Guo D.A., Dias A., El-Nezami H., et al. Traditional Chinese medicine research in the post-genomic era: good practice, priorities, challenges and opportunities. J. Ethnopharmacol. 2012, 140:458-468.
437. Vaidya A. Reverse pharmacological correlates of ayurvedic drug actions. Indian J. Pharm. 2006, 38:311-315.
438. van der Laan J.W., Brightwell J., McAnulty P., Ratky J., Stark C. Regulatory acceptability of the minipig in the development of pharmaceuticals, chemicals and other products. J. Pharmacol. Toxicol. Methods 2010, 62:184-195.
439. Vasilev N., Schmitz C., Dong L., Ritala A., Imseng N., Häkkinen S., et al. Comparison of plant-based expression platforms for the heterologous production of geraniol. Plant Cell Tissue Organ Cult. 2014, 117:373-380.
440. Verpoorte R. Exploration of nature's chemodiversity: the role of secondary metabolites as leads in drug development. Drug Discov. Today 1998, 3:232-238.
441. Verpoorte R. Pharmacognosy in the new millennium: leadfinding and biotechnology. J. Pharm. Pharmacol. 2000, 52:253-262.
442. Vines G. Herbal harvests with a future. Towards Sustainable Sources for Medicinal Plants 2004, Plantlife International, Salisbury, UK, (http://www.plantlife.org.uk/uploads/documents/Herbal-Harvests-with-a-Future.pdf).
443. Vogel H.G. Drug Discovery and Evaluation: Pharmacological Assays; Including a CD-ROM 2002, Springer.
444. Vogl S., Atanasov A.G., Binder M., Bulusu M., Zehl M., Fakhrudin N., et al. The herbal drug Melampyrum pratense L. (Koch): isolation and identification of its bioactive compounds targeting mediators of inflammation. Evid. Based Complement. Alternat. Med. 2013, 2013:395316.
445. Vree T., Breimer D., GINNEKEN C., Rossum J. Identification in hashish of tetrahydrocannabinol, cannabidiol and cannabinol analogues with a methyl side chain. J. Pharm. Pharmacol. 1972, 24:7-12.
446. Wagner H., Ulrich-Merzenich G. Synergy research: approaching a new generation of phytopharmaceuticals. Phytomedicine 2009, 16:97-110.
447. Waltenberger B., Schuster D., Paramapojn S., Gritsanapan W., Wolber G., Rollinger J.M., et al. Predicting cyclooxygenase inhibition by three-dimensional pharmacophoric profiling. Part II: identification of enzyme inhibitors from Prasaplai, a Thai traditional medicine. Phytomedicine 2011, 18:119-133.
448. Wan J.Y., Liu P., Wang H.Y., Qi L.W., Wang C.Z., Li P., et al. Biotransformation and metabolic profile of American ginseng saponins with human intestinal microflora by liquid chromatography quadrupole time-of-flight mass spectrometry. J. Chromatogr. A 2013, 1286:83-92.
449. Wang B., Deng J., Gao Y., Zhu L., He R., Xu Y. The screening toolbox of bioactive substances from natural products: a review. Fitoterapia 2011, 82:1141-1151.
450. Wang Y., Chen S., Yu O. Metabolic engineering of flavonoids in plants and microorganisms. Appl. Microbiol. Biotechnol. 2011, 91:949-956.
451. Wang H., Hu Y.C., Markoulaki S., Welstead G.G., Cheng A.W., Shivalila C.S., et al. TALEN-mediated editing of the mouse Y chromosome. Nat. Biotechnol. 2013, 31:530-532.
452. Wang J., Kong H., Yuan Z., Gao P., Dai W., Hu C., et al. A novel strategy to evaluate the quality of traditional Chinese medicine based on the correlation analysis of chemical fingerprint and biological effect. J. Pharm. Biomed. Anal. 2013, 83:57-64.
453. Wang F., Zhao S., Li F., Zhang B., Qu Y., Sun T., et al. Investigation of antioxidant interactions between Radix astragali and Cimicifuga foetida and identification of synergistic antioxidant compounds. PLoS One 2014, 9:e87221.
454. Wang J.R., Yau L.F., Zhang R., Xia Y., Ma J., Ho H.M., et al. Transformation of ginsenosides from notoginseng by artificial gastric juice can increase cytotoxicity toward cancer cells. J. Agric. Food Chem. 2014, 62:2558-2573.
455. Wang T., Wei J.J., Sabatini D.M., Lander E.S. Genetic screens in human cells using the CRISPR-Cas9 system. Science 2014, 343:80-84.
456. Wani M.C., Taylor H.L., Wall M.E., Coggon P., McPhail A.T. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J. Am. Chem. Soc. 1971, 93:2325-2327.
457. Waszkowycz B., Clark D.E., Gancia E. Outstanding challenges in protein-ligand docking and structure-based virtual screening. Wiley Interdiscip. Rev.: Comput. Mol. Sci. 2011, 1:229-259.
458. Wawrosch C. In vitro cultivation of medicinal plants. Handbook of Medicinal Plants 2005, 261-278. The Haworth Press, New York. Z. Yaniv, U. Bachrach (Eds.).
459. Wawrosch C. In vitro propagation of medicinal plants for conservation and quality assurance. Medicinal Plant Biotechnology 2010, 93-97.
460. Wawrosch C., Schwaiger S., Stuppner H., Kopp B. Lignan formation in hairy root cultures of Edelweiss (Leontopodium nivale ssp. alpinum (Cass.) Greuter). Fitoterapia 2014, 97:219-223.
461. Weathers P.J., Towler M.J., Xu J. Bench to batch: advances in plant cell culture for producing useful products. Appl. Microbiol. Biotechnol. 2010, 85:1339-1351.
462. Wei G., Wang J., Du Y. Total synthesis of solamargine. Bioorg. Med. Chem. Lett. 2011, 21:2930-2933.
463. Wei S.-D., Chen R.-Y., Liao M.-M., Tu N.-W., Zhou H.-C., Lin Y.-M. Antioxidant condensed tannins from Machilus pauhoi leaves. J. Med. Plant Res. 2011, 5:796-804.
464. Wenzel S.C., Muller R. Recent developments towards the heterologous expression of complex bacterial natural product biosynthetic pathways. Curr. Opin. Biotechnol. 2005, 16:594-606.
465. Werner L., Machara A., Hudlicky T. Short chemoenzymic azide-free synthesis of oseltamivir (Tamiflu): approaching the potential for process efficiency. Adv. Synth. Catal. 2010, 352:195-200.
466. White N.J. Qinghaosu (artemisinin): the price of success. Science 2008, 320:330-334.
467. WHO WHO Guidelines on Good Agricultural and Collection Practices (GACP) 2003.
468. Wiedenfeld H., Dumaa M., Malinowski M., Furmanowa M., Narantuya S. Phytochemical and analytical studies of extracts from Rhodiola rosea and Rhodiola quadrifida. Pharmazie 2007, 62:308-311.
469. Wiesrum K.F., Dold A.P., Husselman M., Cocks M. Cultivation of medicinal plants as a tool for biodiversity conservation and poverty alleviation in the Amatola Region, South Africa. Medicinal and Aromatic plants: Agricultural, Commercial, Ecological, Legal, Pharmacological and Social Aspects 2006, 43-57. Springer, Dordrecht. R.J. Bogers, L.E. Craker, D. Lange (Eds.).
470. Wilson S.A., Roberts S.C. Recent advances towards development and commercialization of plant cell culture processes for the synthesis of biomolecules. Plant Biotechnol. J. 2012, 10:249-268.
471. Wilson S.A., Roberts S.C. Metabolic engineering approaches for production of biochemicals in food and medicinal plants. Curr. Opin. Biotechnol. 2014, 26:174-182.
472. Wolber G., Rollinger J.M. Virtual screening and target fishing for natural products using 3D pharmacophores. Computational Chemogenomics 2013, 117-139. Pan Stanford Publishing Pte Ltd., Singapore, (ISBN: 978-9814411394). E. Jacoby (Ed.).
473. Wolfender J.L., Rudaz S., Choi Y.H., Kim H.K. Plant metabolomics: from holistic data to relevant biomarkers. Curr. Med. Chem. 2013, 20:1056-1090.
474. Wolfender J.L., Marti G., Thomas A., Bertrand S. Current approaches and challenges for the metabolite profiling of complex natural extracts. J. Chromatogr. A 2014, (pii: S0021-9673(14)01703-8). 10.1016/j.chroma.2014.10.091.
475. Wood A.J., Lo T.W., Zeitler B., Pickle C.S., Ralston E.J., Lee A.H., et al. Targeted genome editing across species using ZFNs and TALENs. Science 2011, 333:307.
476. Woodward R.B., Cava M.P., Ollis W.D., Hunger A., Daeniker I.U., Schenker K. Total synthesis of strychnine. J. Am. Chem. Soc. 1954, 76:4749-4751.
477. Xiao J., Hogger P. Metabolism of dietary flavonoids in liver microsomes. Curr. Drug Metab. 2013, 14:381-391.
478. Xiao Z.Y., Mu Q., Shiu W.K., Zeng Y.H., Gibbons S. Polyisoprenylated benzoylphloroglucinol derivatives from Hypericum sampsonii. J. Nat. Prod. 2007, 70:1779-1782.
479. Xie C., Kang J., Chen J.R., Nagarajan S., Badger T.M., Wu X. Phenolic acids are in vivo atheroprotective compounds appearing in the serum of rats after blueberry consumption. J. Agric. Food Chem. 2011, 59:10381-10387.
480. Xie L.W., Atanasov A.G., Guo D.A., Malainer C., Zhang J.X., Zehl M., et al. Activity-guided isolation of NF-kappaB inhibitors and PPARgamma agonists from the root bark of Lycium chinense Miller. J. Ethnopharmacol. 2014, 152:470-477.
481. Yu L., Huang H., Yu L.L., Wang T.T. Utility of hesperidinase for food function research: enzymatic digestion of botanical extracts alters cellular antioxidant capacities and anti-inflammatory properties. J. Agric. Food Chem. 2014, 62:8640-8647.
482. Yuan J.L., Ding W.P., Shi J.P., Lu Z.Z., Zhou B.N., Erdelmeier C.A., et al. Studies on the antifertility components from Marsdenia koi. J. Tongji Med. Univ. 1991, 11:165-168.
483. Yuliana N.D., Khatib A., Choi Y.H., Verpoorte R. Metabolomics for bioactivity assessment of natural products. Phytother. Res. 2011, 25:157-169.
484. Yun U.W., Yan Z., Amir R., Hong S., Jin Y.W., Lee E.K., et al. Plant natural products: history, limitations and the potential of cambial meristematic cells. Biotechnol. Genet. Eng. Rev. 2012, 28:47-59.
485. Zaman G.J., Garritsen A., de Boer T., van Boeckel C.A. Fluorescence assays for high-throughput screening of protein kinases. Comb. Chem. High Throughput Screen. 2003, 6:313-320.
486. Zambrowicz B.P., Sands A.T. Knockouts model the 100 best-selling drugs - will they model the next 100?. Nat. Rev. Drug Discov. 2003, 2:38-51.
487. Zenk M.H., Juenger M. Evolution and current status of the phytochemistry of nitrogenous compounds. Phytochemistry 2007, 68:2757-2772.
488. Zhang H.J., Tamez P.A., Vu D.H., Ghee T.T., Nguyen V.H., Le T.X., et al. Antimalarial compounds from Rhaphidophora decursiva. J. Nat. Prod. 2001, 64:772-777.
489. Zhang H., Wang Y., Pfeifer B.A. Bacterial hosts for natural product production. Mol. Pharm. 2008, 5:212-225.
490. Zhang L.L., Lin Y.M., Zhou H.C., Wei S.D., Chen J.H. Condensed tannins from mangrove species Kandelia candel and Rhizophora mangle and their antioxidant activity. Molecules 2010, 15:420-431.
491. Zhang H., Xu X., Chen L., Chen J., Hu L., Jiang H., et al. Molecular determinants of magnolol targeting both RXRalpha and PPARgamma. PLoS One 2011, 6:e28253.
492. Zhang D., Luo G., Ding X., Lu C. Preclinical experimental models of drug metabolism and disposition in drug discovery and development. Acta Pharm. Sin. B 2012, 2:549-561.
493. Zhao L., Brinton R.D. Structure-based virtual screening for plant-based ERbeta-selective ligands as potential preventative therapy against age-related neurodegenerative diseases. J. Med. Chem. 2005, 48:3463-3466.
494. Zhao J., Davis L.C., Verpoorte R. Elicitor signal transduction leading to production of plant secondary metabolites. Biotechnol. Adv. 2005, 23:283-333.
495. Zheng W., Thorne N., McKew J.C. Phenotypic screens as a renewed approach for drug discovery. Drug Discov. Today 2013, 18:1067-1073.
496. Zhou J., Du G., Chen J. Novel fermentation processes for manufacturing plant natural products. Curr. Opin. Biotechnol. 2014, 25:17-23.
497. Zhu Y.-P. Chinese Materia Medica. Chemistry, Pharmacology and Applications 1998, 1-2. Harwood Academic Press, Amsterdam, Netherlands.
498. Zhu C., Cook S.P. A concise synthesis of (+)-artemisinin. J. Am. Chem. Soc. 2012, 134:13577-13579.
499. Zhu M., Phillipson J.D., Greengrass P.M., Bowery N.E., Cai Y. Plant polyphenols: biologically active compounds or non-selective binders to protein?. Phytochemistry 1997, 44:441-447.
500. Zhu J., Van de Ven W.J., Verbiest T., Koeckelberghs G., Chen C., Cui Y., et al. Polyphenols can inhibit furin in vitro as a result of the reactivity of their auto-oxidation products to proteins. Curr. Med. Chem. 2013, 20:840-850.
501. Ziegler S., Pries V., Hedberg C., Waldmann H. Target identification for small bioactive molecules: finding the needle in the haystack. Angew. Chem. Int. Ed. Engl. 2013, 52:2744-2792.
502. Zimmermann G.R., Lehár J., Keith C.T. Multi-target therapeutics: when the whole is greater than the sum of the parts. Drug Discov. Today 2007, 12:34-42.
503. Zou L., Harkey M.R., Henderson G.L. Effects of intrinsic fluorescence and quenching on fluorescence-based screening of natural products. Phytomedicine 2002, 9:263-267.